Breaking News

Yesterday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Conference/Events
American Academy of Neurology to hold a virtual meeting » 04:55
04/22/21
04/22
04:55
04/22/21
04:55
ABBV

AbbVie

$110.81 /

+1.78 (+1.63%)

, ABC

AmerisourceBergen

$121.16 /

+0.69 (+0.57%)

, ABT

Abbott

$122.61 /

+2.62 (+2.18%)

, ACAD

Acadia Pharmaceuticals

$21.46 /

+0.67 (+3.22%)

, ALNY

Alnylam

$137.67 /

+2 (+1.47%)

, BIIB

Biogen

$269.13 /

-3.84 (-1.41%)

, BMY

Bristol-Myers

$66.32 /

+0.265 (+0.40%)

, BHVN

Biohaven Pharmaceutical

$75.13 /

+1.5 (+2.04%)

, CPRX

Catalyst Pharmaceuticals

$4.52 /

+0.13 (+2.96%)

, DGX

Quest Diagnostics

$130.08 /

+0.79 (+0.61%)

, DNA

Bought by RHHBY

$94.97 /

+ (+0.00%)

, HZNP

Horizon Therapeutics

$93.52 /

+2.45 (+2.69%)

, LIVN

LivaNova

$83.05 /

+1.63 (+2.00%)

, LLY

Eli Lilly

$191.00 /

+0.45 (+0.24%)

, MDT

Medtronic

$130.19 /

+1.9 (+1.48%)

, NVS

Novartis

$88.67 /

+0.84 (+0.96%)

, NVTA

Invitae

$36.05 /

+1.795 (+5.24%)

, PFE

Pfizer

$39.53 /

+0.5 (+1.28%)

, PTCT

PTC Therapeutics

$45.78 /

-0.545 (-1.18%)

, RETA

Reata Pharmaceuticals

$90.75 /

+1.17 (+1.31%)

, SNY

Sanofi

$52.43 /

+0.44 (+0.85%)

, SUPN

Supernus

$31.37 /

+0.61 (+1.98%)

, TAK

Takeda Pharmaceutical

$16.93 /

+0.095 (+0.56%)

, TEVA

Teva

$10.25 /

+0.135 (+1.33%)

, TGTX

TG Therapeutics

$40.61 /

+0.64 (+1.60%)

, ZGNX

Zogenix

$18.95 /

+0.09 (+0.48%)

, AVDL

Avadel Pharmaceuticals

$8.46 /

+0.265 (+3.24%)

, JNJ

Johnson & Johnson

$166.61 /

+0.16 (+0.10%)

73rd Annual Virtual…

73rd Annual Virtual Meeting of AAN will be held on April 17-22. Webcast Link

ShowHide Related Items >><<
ZGNX Zogenix
$18.95 /

+0.09 (+0.48%)

TGTX TG Therapeutics
$40.61 /

+0.64 (+1.60%)

TEVA Teva
$10.25 /

+0.135 (+1.33%)

TAK Takeda Pharmaceutical
$16.93 /

+0.095 (+0.56%)

SUPN Supernus
$31.37 /

+0.61 (+1.98%)

SNY Sanofi
$52.43 /

+0.44 (+0.85%)

RETA Reata Pharmaceuticals
$90.75 /

+1.17 (+1.31%)

PTCT PTC Therapeutics
$45.78 /

-0.545 (-1.18%)

PFE Pfizer
$39.53 /

+0.5 (+1.28%)

NVTA Invitae
$36.05 /

+1.795 (+5.24%)

NVS Novartis
$88.67 /

+0.84 (+0.96%)

MDT Medtronic
$130.19 /

+1.9 (+1.48%)

LLY Eli Lilly
$191.00 /

+0.45 (+0.24%)

LIVN LivaNova
$83.05 /

+1.63 (+2.00%)

JNJ Johnson & Johnson
$166.61 /

+0.16 (+0.10%)

HZNP Horizon Therapeutics
$93.52 /

+2.45 (+2.69%)

DGX Quest Diagnostics
$130.08 /

+0.79 (+0.61%)

CPRX Catalyst Pharmaceuticals
$4.52 /

+0.13 (+2.96%)

BMY Bristol-Myers
$66.32 /

+0.265 (+0.40%)

BIIB Biogen
$269.13 /

-3.84 (-1.41%)

BHVN Biohaven Pharmaceutical
$75.13 /

+1.5 (+2.04%)

AVDL Avadel Pharmaceuticals
$8.46 /

+0.265 (+3.24%)

ALNY Alnylam
$137.67 /

+2 (+1.47%)

ACAD Acadia Pharmaceuticals
$21.46 /

+0.67 (+3.22%)

ABT Abbott
$122.61 /

+2.62 (+2.18%)

ABC AmerisourceBergen
$121.16 /

+0.69 (+0.57%)

ABBV AbbVie
$110.81 /

+1.78 (+1.63%)

ABBV AbbVie
$110.81 /

+1.78 (+1.63%)

04/21/21 Citi
Citi sees 'material upside' for AbbVie, Bristol-Myers after Pfizer data
04/21/21 Citi
Citi opens '90-day positive catalyst' on AbbVie, reiterates Buy rating
04/06/21 RBC Capital
AbbVie transferred with an Outperform at RBC Capital
04/01/21 Piper Sandler
Integra to benefit from FDA safety communication, says Piper Sandler
ABC AmerisourceBergen
$121.16 /

+0.69 (+0.57%)

03/09/21 Baird
AmerisourceBergen remains top pick following results, says Baird
02/09/21 Mizuho
AmerisourceBergen price target raised to $114 from $104 at Mizuho
02/08/21 Cowen
AmerisourceBergen price target raised to $150 from $145 at Cowen
02/04/21 Evercore ISI
AmerisourceBergen upgraded to Outperform after Q1 report at Evercore ISI
ABT Abbott
$122.61 /

+2.62 (+2.18%)

04/15/21 Atlantic Equities
Atlantic Equities starts Abbott at Neutral
04/15/21 Atlantic Equities
Abbott initiated with a Neutral at Atlantic Equities
03/16/21 Piper Sandler
Abbott study challenging Abiomed's Impella halted, says Piper Sandler
03/10/21 Wells Fargo
Wells says Quidel Covid testing comments not a direct read through to Abbott
ACAD Acadia Pharmaceuticals
$21.46 /

+0.67 (+3.22%)

04/07/21 Needham
Acadia price target lowered to $30 from $44 at Needham
04/07/21 H.C. Wainwright
Acadia downgraded to Neutral from Buy at H.C. Wainwright
04/06/21 SVB Leerink
Acadia price target lowered to $31 from $63 at SVB Leerink
04/06/21 Jefferies
Acadia downgraded to Hold at Jefferies after dementia-related psychosis CRL
ALNY Alnylam
$137.67 /

+2 (+1.47%)

02/22/21 Guggenheim
Alnylam downgraded to Neutral from Buy at Guggenheim
02/12/21
Fly Intel: Top five analyst downgrades
02/12/21 Barclays
Alnylam price target raised to $196 from $162 at Barclays
02/12/21 Citi
Alnylam downgraded to Neutral from Buy at Citi
BIIB Biogen
$269.13 /

-3.84 (-1.41%)

04/19/21 Jefferies
Biogen 'may have best risk/reward among large caps' in 2021-23, says Jefferies
04/13/21 Roth Capital
Roth Capital sees Applied Genetic's XLRS licensing as vote of confidence
04/12/21 Oppenheimer
Sage Therapeutics data support 'enthusiasm' for SAGE-324 in ET, says Oppenheimer
04/12/21 Wedbush
Biogen price target raised to $245 from $236 at Wedbush
BMY Bristol-Myers
$66.32 /

+0.265 (+0.40%)

04/21/21 Citi
Citi opens '90-day catalyst watch' on Bristol-Myers, reiterates Buy
04/13/21 Truist
Bristol-Myers upgraded to Buy at Truist on improving pipeline asset visibility
04/13/21 Truist
Bristol-Myers upgraded to Buy from Hold at Truist
BHVN Biohaven Pharmaceutical
$75.13 /

+1.5 (+2.04%)

04/01/21 Piper Sandler
Piper migraine survey bearish for Amgen, bullish for Biohaven
03/11/21
Fly Intel: Top five analyst initiations
03/11/21 UBS
Biohaven Pharmaceutical initiated with a Buy at UBS
03/02/21 Mizuho
Biohaven Pharmaceutical price target raised to $103 from $93 at Mizuho
CPRX Catalyst Pharmaceuticals
$4.52 /

+0.13 (+2.96%)

03/16/21 Piper Sandler
Catalyst business continues to generate cash flow, says Piper Sandler
01/07/21 Piper Sandler
Piper says Catalyst's Firdapse commercial business performing as expected
01/06/21 Piper Sandler
Catalyst Firdapse commercial business performing as expected, says Piper Sandler
11/10/20 Piper Sandler
Catalyst Pharmaceuticals price target lowered to $5.50 from $6 at Piper Sandler
DGX Quest Diagnostics
$130.08 /

+0.79 (+0.61%)

03/12/21 Baird
Quest Diagnostics downgraded to Neutral from Outperform at Baird
01/29/21 Citi
Quest Diagnostics price target raised to $158 from $151 at Citi
12/17/20 Morgan Stanley
Morgan Stanley cuts Quest Diagnostics to Equal Weight ahead of 2022 slowdown
12/17/20 Morgan Stanley
Quest Diagnostics downgraded to Equal Weight from Overweight at Morgan Stanley
DNA Bought by RHHBY
$94.97 /

+ (+0.00%)

HZNP Horizon Therapeutics
$93.52 /

+2.45 (+2.69%)

03/25/21 Guggenheim
Horizon Therapeutics price target raised to $120 from $115 at Guggenheim
03/22/21
Fly Intel: Top five analyst initiations
03/22/21 Morgan Stanley
Horizon Therapeutics resumed with an Overweight at Morgan Stanley
03/18/21 Citi
Horizon Therapeutics price target raised to $120 from $116 at Citi
LIVN LivaNova
$83.05 /

+1.63 (+2.00%)

04/19/21 Piper Sandler
LivaNova HF enrollment milestone a key step toward approval, says Piper Sandler
04/13/21 Piper Sandler
LivaNova price target raised to $92 from $81 at Piper Sandler
03/03/21
Fly Intel: Top five analyst downgrades
03/03/21 Berenberg
Berenberg cuts LivaNova EPS forecasts on investments, downgrades to Hold
LLY Eli Lilly
$191.00 /

+0.45 (+0.24%)

04/12/21 Benchmark
Benchmark sees full FDA approval of Regeneron's REGEN-COV coming
04/06/21 JPMorgan
JPMorgan survey 'broadly positive' on Eli Lilly Alzheimer's drug
03/24/21 BMO Capital
AbCellera price target lowered to $59 from $61 at BMO Capital
03/17/21 Mizuho
AbbVie's FDA request show Xeljanz concerns may bleed to Rinvoq, says Mizuho
MDT Medtronic
$130.19 /

+1.9 (+1.48%)

04/15/21 Atlantic Equities
Atlantic Equities starts Medtronic at Overweight
04/15/21 Atlantic Equities
Medtronic initiated with an Overweight at Atlantic Equities
04/05/21 Citi
Citi opens positive catalyst watches on four medical supply stocks
02/24/21 Cowen
Medtronic price target raised to $135 from $120 at Cowen
NVS Novartis
$88.67 /

+0.84 (+0.96%)

04/19/21 UBS
Novartis price target raised to CHF 96 from CHF 95 at UBS
04/05/21 Morgan Stanley
Regenxbio AAV9 patent challenged by Passage Bio, says Morgan Stanley
03/23/21 Societe Generale
Novartis price target raised to CHF 107 from CHF 104 at Societe Generale
03/22/21 Bernstein
Novartis initiated with a Market Perform at Bernstein
NVTA Invitae
$36.05 /

+1.795 (+5.24%)

04/05/21 Oppenheimer
Oppenheimer upgrades Invitae on valuation, sees potential high $50s stock
04/05/21 Oppenheimer
Invitae upgraded to Outperform from Perform at Oppenheimer
02/18/21 Ladenburg
Invitae upgraded to Buy with $58 price target at Ladenburg
02/18/21 Ladenburg
Invitae upgraded to Buy from Neutral at Ladenburg
PFE Pfizer
$39.53 /

+0.5 (+1.28%)

04/13/21 Morgan Stanley
Morgan Stanley says J&J news could improve 2022 outlook for mRNA vaccine makers
04/13/21 JPMorgan
Vaccine pause 'incremental negative' for J&J, says JPMorgan
04/09/21
Pfizer to host conference call
PTCT PTC Therapeutics
$45.78 /

-0.545 (-1.18%)

03/29/21 RBC Capital
PTC Therapeutics upgraded to Sector Perform at RBC Capital on valuation
03/29/21 RBC Capital
PTC Therapeutics upgraded to Sector Perform from Underperform at RBC Capital
02/26/21 Cantor Fitzgerald
PTC Therapeutics price target lowered to $75 from $81 at Cantor Fitzgerald
02/12/21 BofA
PTC Therapeutics downgraded to Neutral from Buy at BofA
RETA Reata Pharmaceuticals
$90.75 /

+1.17 (+1.31%)

11/25/20 Citi
Reata Pharmaceuticals price target lowered to $234 from $260 at Citi
11/10/20 Cantor Fitzgerald
Reata Pharmaceuticals price target raised to $220 from $169 at Cantor Fitzgerald
11/10/20 Citi
Reata Pharmaceuticals price target raised to $260 from $244 at Citi
08/11/20 Cantor Fitzgerald
Reata Pharmaceuticals price target lowered to $169 from $275 at Cantor Fitzgerald
SNY Sanofi
$52.43 /

+0.44 (+0.85%)

04/06/21 Barclays
Sanofi price target raised to EUR 85 from EUR 80 at Barclays
02/23/21 BofA
BofA adds Heineken and IAG, removes Roche and Sanofi from Europe 1 list
02/10/21 Morgan Stanley
Sanofi price target raised to EUR 104 from EUR 101 at Morgan Stanley
02/05/21 Piper Sandler
Piper reiterates Overweight on Kymera after Sanofi capital markets day
SUPN Supernus
$31.37 /

+0.61 (+1.98%)

04/13/21 Jefferies
Supernus upgraded to Buy after survey work at Jefferies
04/13/21 Jefferies
Supernus upgraded to Buy from Hold at Jefferies
02/03/21 Piper Sandler
Supernus price target raised to $35 from $30 at Piper Sandler
06/16/20 Piper Sandler
Supernus upgraded to Overweight from Neutral at Piper Sandler
TAK Takeda Pharmaceutical
$16.93 /

+0.095 (+0.56%)

04/19/21 JPMorgan
Takeda Pharmaceutical downgraded to Neutral on R&D investments at JPMorgan
04/19/21 JPMorgan
Takeda Pharmaceutical downgraded to Neutral from Overweight at JPMorgan
04/15/21 Oppenheimer
Molecular Templates price target lowered to $13 from $18 at Oppenheimer
04/05/21
Fly Intel: Top five analyst downgrades
TEVA Teva
$10.25 /

+0.135 (+1.33%)

04/06/21 RBC Capital
Teva transferred with a Sector Perform at RBC Capital
01/26/21 Piper Sandler
Amarin in 'strong position' against Health Net, says Piper Sandler
12/21/20 Gabelli
Teva named 'Best Idea for 2021' at Gabelli
11/27/20 H.C. Wainwright
Corcept Therapeutics price target raised to $32 from $22 at H.C. Wainwright
TGTX TG Therapeutics
$40.61 /

+0.64 (+1.60%)

04/20/21
Fly Intel: Top five analyst initiations
04/20/21 Goldman Sachs
TG Therapeutics initiated with a Neutral at Goldman Sachs
04/19/21 Cantor Fitzgerald
TG Therapeutics price target raised to $74 from $68 at Cantor Fitzgerald
04/19/21 H.C. Wainwright
TG Therapeutics price target raised to $89 from $79 at H.C. Wainwright
ZGNX Zogenix
$18.95 /

+0.09 (+0.48%)

04/06/21 Evercore ISI
Evercore starts 'compelling' Arena spinoff Longboard at Outperform
04/06/21 Citi
Longboard Pharmaceuticals initiated with a Buy at Citi
02/03/21 Mizuho
Jazz deal for GW Pharma has positive read through to Zogenix, says Mizuho
12/04/20 Mizuho
Zogenix collaboration step in right direction, says Mizuho
AVDL Avadel Pharmaceuticals
$8.46 /

+0.265 (+3.24%)

03/10/21 H.C. Wainwright
Avadel Pharmaceuticals price target raised to $17 from $15 at H.C. Wainwright
01/25/21 Craig-Hallum
Avadel Pharmaceuticals assumed with a Buy rating at Craig-Hallum
08/28/20 Oppenheimer
Uwarranted pressure creates buying opportunity for Avadel, says Oppenheimer
08/28/20 SVB Leerink
Avadel selloff on Jazz competition worries overdone, says SVB Leerink
JNJ Johnson & Johnson
$166.61 /

+0.16 (+0.10%)

04/19/21 Chardan
Chardan sees J&J moving forward with Emergent if observations are minor
04/14/21 Guggenheim
Emergent BioSolutions price target lowered to $110 from $130 at Guggenheim
04/13/21 Goldman Sachs
J&J vaccine had numerical blood clot imbalance in trial, says Goldman Sachs
ZGNX Zogenix
$18.95 /

+0.09 (+0.48%)

TGTX TG Therapeutics
$40.61 /

+0.64 (+1.60%)

TEVA Teva
$10.25 /

+0.135 (+1.33%)

TAK Takeda Pharmaceutical
$16.93 /

+0.095 (+0.56%)

SUPN Supernus
$31.37 /

+0.61 (+1.98%)

SNY Sanofi
$52.43 /

+0.44 (+0.85%)

RETA Reata Pharmaceuticals
$90.75 /

+1.17 (+1.31%)

PTCT PTC Therapeutics
$45.78 /

-0.545 (-1.18%)

PFE Pfizer
$39.53 /

+0.5 (+1.28%)

NVTA Invitae
$36.05 /

+1.795 (+5.24%)

NVS Novartis
$88.67 /

+0.84 (+0.96%)

MDT Medtronic
$130.19 /

+1.9 (+1.48%)

LLY Eli Lilly
$191.00 /

+0.45 (+0.24%)

LIVN LivaNova
$83.05 /

+1.63 (+2.00%)

JNJ Johnson & Johnson
$166.61 /

+0.16 (+0.10%)

HZNP Horizon Therapeutics
$93.52 /

+2.45 (+2.69%)

DGX Quest Diagnostics
$130.08 /

+0.79 (+0.61%)

CPRX Catalyst Pharmaceuticals
$4.52 /

+0.13 (+2.96%)

BMY Bristol-Myers
$66.32 /

+0.265 (+0.40%)

BIIB Biogen
$269.13 /

-3.84 (-1.41%)

BHVN Biohaven Pharmaceutical
$75.13 /

+1.5 (+2.04%)

AVDL Avadel Pharmaceuticals
$8.46 /

+0.265 (+3.24%)

ALNY Alnylam
$137.67 /

+2 (+1.47%)

ACAD Acadia Pharmaceuticals
$21.46 /

+0.67 (+3.22%)

ABT Abbott
$122.61 /

+2.62 (+2.18%)

ABC AmerisourceBergen
$121.16 /

+0.69 (+0.57%)

ABBV AbbVie
$110.81 /

+1.78 (+1.63%)

  • 16
    Mar
  • 22
    Jan
  • 15
    Dec
  • 02
    Dec
  • 07
    Aug
  • 15
    May
  • 29
    Apr
TEVA Teva
$10.25 /

+0.135 (+1.33%)

SNY Sanofi
$52.43 /

+0.44 (+0.85%)

PFE Pfizer
$39.53 /

+0.5 (+1.28%)

NVS Novartis
$88.67 /

+0.84 (+0.96%)

LLY Eli Lilly
$191.00 /

+0.45 (+0.24%)

LIVN LivaNova
$83.05 /

+1.63 (+2.00%)

JNJ Johnson & Johnson
$166.61 /

+0.16 (+0.10%)

BMY Bristol-Myers
$66.32 /

+0.265 (+0.40%)

BIIB Biogen
$269.13 /

-3.84 (-1.41%)

ALNY Alnylam
$137.67 /

+2 (+1.47%)

ABT Abbott
$122.61 /

+2.62 (+2.18%)

ABC AmerisourceBergen
$121.16 /

+0.69 (+0.57%)

ABBV AbbVie
$110.81 /

+1.78 (+1.63%)

ZGNX Zogenix
$18.95 /

+0.09 (+0.48%)

TGTX TG Therapeutics
$40.61 /

+0.64 (+1.60%)

TEVA Teva
$10.25 /

+0.135 (+1.33%)

TAK Takeda Pharmaceutical
$16.93 /

+0.095 (+0.56%)

SUPN Supernus
$31.37 /

+0.61 (+1.98%)

SNY Sanofi
$52.43 /

+0.44 (+0.85%)

RETA Reata Pharmaceuticals
$90.75 /

+1.17 (+1.31%)

PTCT PTC Therapeutics
$45.78 /

-0.545 (-1.18%)

PFE Pfizer
$39.53 /

+0.5 (+1.28%)

NVTA Invitae
$36.05 /

+1.795 (+5.24%)

NVS Novartis
$88.67 /

+0.84 (+0.96%)

LLY Eli Lilly
$191.00 /

+0.45 (+0.24%)

JNJ Johnson & Johnson
$166.61 /

+0.16 (+0.10%)

HZNP Horizon Therapeutics
$93.52 /

+2.45 (+2.69%)

DGX Quest Diagnostics
$130.08 /

+0.79 (+0.61%)

CPRX Catalyst Pharmaceuticals
$4.52 /

+0.13 (+2.96%)

BMY Bristol-Myers
$66.32 /

+0.265 (+0.40%)

BIIB Biogen
$269.13 /

-3.84 (-1.41%)

BHVN Biohaven Pharmaceutical
$75.13 /

+1.5 (+2.04%)

AVDL Avadel Pharmaceuticals
$8.46 /

+0.265 (+3.24%)

ACAD Acadia Pharmaceuticals
$21.46 /

+0.67 (+3.22%)

ABT Abbott
$122.61 /

+2.62 (+2.18%)

ABC AmerisourceBergen
$121.16 /

+0.69 (+0.57%)

ABBV AbbVie
$110.81 /

+1.78 (+1.63%)

ZGNX Zogenix
$18.95 /

+0.09 (+0.48%)

TGTX TG Therapeutics
$40.61 /

+0.64 (+1.60%)

TEVA Teva
$10.25 /

+0.135 (+1.33%)

TAK Takeda Pharmaceutical
$16.93 /

+0.095 (+0.56%)

PFE Pfizer
$39.53 /

+0.5 (+1.28%)

NVTA Invitae
$36.05 /

+1.795 (+5.24%)

MDT Medtronic
$130.19 /

+1.9 (+1.48%)

LLY Eli Lilly
$191.00 /

+0.45 (+0.24%)

JNJ Johnson & Johnson
$166.61 /

+0.16 (+0.10%)

HZNP Horizon Therapeutics
$93.52 /

+2.45 (+2.69%)

DGX Quest Diagnostics
$130.08 /

+0.79 (+0.61%)

BMY Bristol-Myers
$66.32 /

+0.265 (+0.40%)

BIIB Biogen
$269.13 /

-3.84 (-1.41%)

ABT Abbott
$122.61 /

+2.62 (+2.18%)

ABC AmerisourceBergen
$121.16 /

+0.69 (+0.57%)

ABBV AbbVie
$110.81 /

+1.78 (+1.63%)

Wednesday
Hot Stocks
KemPharm confirms receipt of $10M milestone payment for FDA approval of AZSTARYS » 16:46
04/21/21
04/21
16:46
04/21/21
16:46
KMPH

KemPharm

$8.91 /

-0.005 (-0.06%)

The company states:…

The company states: "KemPharm announced receipt of a regulatory milestone payment of $10 million for the FDA approval of AZSTARYS(TM) in accordance with the recently amended definitive collaboration and license agreement with Commave Therapeutics, SA, an affiliate of Gurnet Point Capital. The License Agreement provides for an exclusive worldwide license to develop, manufacture and commercialize KemPharm's product candidates containing serdexmethylphenidate (SDX) and d-methylphenidate , including AZSTARYS, a once-daily product for the treatment of attention deficit hyperactivity disorder in patients age six years and older. AZSTARYS was approved by the U.S. Food and Drug Administration on March 2, 2021. As previously announced, Corium, Inc., a portfolio company of Gurnet Point Capital, is leading U.S. commercialization efforts for AZSTARYS".

ShowHide Related Items >><<
KMPH KemPharm
$8.91 /

-0.005 (-0.06%)

KMPH KemPharm
$8.91 /

-0.005 (-0.06%)

03/04/21 H.C. Wainwright
KemPharm downgraded to Neutral from Buy at H.C. Wainwright
01/25/21 Roth Capital
KemPharm initiated with a Buy at Roth Capital
05/20/20 H.C. Wainwright
KemPharm price target lowered to $1.50 from $2.50 at H.C. Wainwright
KMPH KemPharm
$8.91 /

-0.005 (-0.06%)

KMPH KemPharm
$8.91 /

-0.005 (-0.06%)

Conference/Events
American Academy of Neurology to hold a virtual meeting » 04:55
04/21/21
04/21
04:55
04/21/21
04:55
ABBV

AbbVie

$109.03 /

+0.43 (+0.40%)

, ABC

AmerisourceBergen

$120.47 /

+0.98 (+0.82%)

, ABT

Abbott

$120.00 /

-4.67 (-3.75%)

, ACAD

Acadia Pharmaceuticals

$20.79 /

+0.01 (+0.05%)

, ALNY

Alnylam

$135.74 /

-1.55 (-1.13%)

, BIIB

Biogen

$272.95 /

+4.05 (+1.51%)

, BMY

Bristol-Myers

$66.06 /

+0.4 (+0.61%)

, BHVN

Biohaven Pharmaceutical

$73.50 /

+1.22 (+1.69%)

, CPRX

Catalyst Pharmaceuticals

$4.39 /

+0.07 (+1.62%)

, DGX

Quest Diagnostics

$129.37 /

-1.69 (-1.29%)

, DNA

Bought by RHHBY

$94.97 /

+ (+0.00%)

, HZNP

Horizon Therapeutics

$91.07 /

+0.88 (+0.98%)

, LIVN

LivaNova

$81.39 /

+0.74 (+0.92%)

, LLY

Eli Lilly

$190.55 /

+0.85 (+0.45%)

, MDT

Medtronic

$128.29 /

+2.13 (+1.69%)

, NVS

Novartis

$87.84 /

-0.52 (-0.59%)

, NVTA

Invitae

$34.25 /

-1.08 (-3.06%)

, PFE

Pfizer

$39.03 /

+0.09 (+0.23%)

, PTCT

PTC Therapeutics

$46.26 /

-1.27 (-2.67%)

, RETA

Reata Pharmaceuticals

$89.28 /

-1.62 (-1.78%)

, SNY

Sanofi

$51.98 /

+0.12 (+0.23%)

, SUPN

Supernus

$30.69 /

-0.24 (-0.78%)

, TAK

Takeda Pharmaceutical

$16.84 /

-0.12 (-0.71%)

, TEVA

Teva

$10.12 /

-0.175 (-1.70%)

, TGTX

TG Therapeutics

$39.95 /

-2.88 (-6.72%)

, ZGNX

Zogenix

$18.79 /

-0.1 (-0.53%)

, AVDL

Avadel Pharmaceuticals

$8.17 /

-0.3 (-3.54%)

, JNJ

Johnson & Johnson

$166.47 /

+3.66 (+2.25%)

73rd Annual Virtual…

73rd Annual Virtual Meeting of AAN will be held on April 17-22. Webcast Link

ShowHide Related Items >><<
ZGNX Zogenix
$18.79 /

-0.1 (-0.53%)

TGTX TG Therapeutics
$39.95 /

-2.88 (-6.72%)

TEVA Teva
$10.12 /

-0.175 (-1.70%)

TAK Takeda Pharmaceutical
$16.84 /

-0.12 (-0.71%)

SUPN Supernus
$30.69 /

-0.24 (-0.78%)

SNY Sanofi
$51.98 /

+0.12 (+0.23%)

RETA Reata Pharmaceuticals
$89.28 /

-1.62 (-1.78%)

PTCT PTC Therapeutics
$46.26 /

-1.27 (-2.67%)

PFE Pfizer
$39.03 /

+0.09 (+0.23%)

NVTA Invitae
$34.25 /

-1.08 (-3.06%)

NVS Novartis
$87.84 /

-0.52 (-0.59%)

MDT Medtronic
$128.29 /

+2.13 (+1.69%)

LLY Eli Lilly
$190.55 /

+0.85 (+0.45%)

LIVN LivaNova
$81.39 /

+0.74 (+0.92%)

JNJ Johnson & Johnson
$166.47 /

+3.66 (+2.25%)

HZNP Horizon Therapeutics
$91.07 /

+0.88 (+0.98%)

DGX Quest Diagnostics
$129.37 /

-1.69 (-1.29%)

CPRX Catalyst Pharmaceuticals
$4.39 /

+0.07 (+1.62%)

BMY Bristol-Myers
$66.06 /

+0.4 (+0.61%)

BIIB Biogen
$272.95 /

+4.05 (+1.51%)

BHVN Biohaven Pharmaceutical
$73.50 /

+1.22 (+1.69%)

AVDL Avadel Pharmaceuticals
$8.17 /

-0.3 (-3.54%)

ALNY Alnylam
$135.74 /

-1.55 (-1.13%)

ACAD Acadia Pharmaceuticals
$20.79 /

+0.01 (+0.05%)

ABT Abbott
$120.00 /

-4.67 (-3.75%)

ABC AmerisourceBergen
$120.47 /

+0.98 (+0.82%)

ABBV AbbVie
$109.03 /

+0.43 (+0.40%)

ABBV AbbVie
$109.03 /

+0.43 (+0.40%)

04/06/21 RBC Capital
AbbVie transferred with an Outperform at RBC Capital
04/01/21 Piper Sandler
Integra to benefit from FDA safety communication, says Piper Sandler
04/01/21 Piper Sandler
Piper migraine survey bearish for Amgen, bullish for Biohaven
03/17/21 JPMorgan
AbbVie selloff on Rinvoq deal 'appears overdone,' says JPMorgan
ABC AmerisourceBergen
$120.47 /

+0.98 (+0.82%)

03/09/21 Baird
AmerisourceBergen remains top pick following results, says Baird
02/09/21 Mizuho
AmerisourceBergen price target raised to $114 from $104 at Mizuho
02/08/21 Cowen
AmerisourceBergen price target raised to $150 from $145 at Cowen
02/04/21 Evercore ISI
AmerisourceBergen upgraded to Outperform after Q1 report at Evercore ISI
ABT Abbott
$120.00 /

-4.67 (-3.75%)

04/15/21 Atlantic Equities
Atlantic Equities starts Abbott at Neutral
04/15/21 Atlantic Equities
Abbott initiated with a Neutral at Atlantic Equities
03/16/21 Piper Sandler
Abbott study challenging Abiomed's Impella halted, says Piper Sandler
03/10/21 Wells Fargo
Wells says Quidel Covid testing comments not a direct read through to Abbott
ACAD Acadia Pharmaceuticals
$20.79 /

+0.01 (+0.05%)

04/07/21 Needham
Acadia price target lowered to $30 from $44 at Needham
04/07/21 H.C. Wainwright
Acadia downgraded to Neutral from Buy at H.C. Wainwright
04/06/21 SVB Leerink
Acadia price target lowered to $31 from $63 at SVB Leerink
04/06/21 Jefferies
Acadia downgraded to Hold at Jefferies after dementia-related psychosis CRL
ALNY Alnylam
$135.74 /

-1.55 (-1.13%)

02/22/21 Guggenheim
Alnylam downgraded to Neutral from Buy at Guggenheim
02/12/21
Fly Intel: Top five analyst downgrades
02/12/21 Barclays
Alnylam price target raised to $196 from $162 at Barclays
02/12/21 Citi
Alnylam downgraded to Neutral from Buy at Citi
BIIB Biogen
$272.95 /

+4.05 (+1.51%)

04/19/21 Jefferies
Biogen 'may have best risk/reward among large caps' in 2021-23, says Jefferies
04/13/21 Roth Capital
Roth Capital sees Applied Genetic's XLRS licensing as vote of confidence
04/12/21 Oppenheimer
Sage Therapeutics data support 'enthusiasm' for SAGE-324 in ET, says Oppenheimer
04/12/21 Wedbush
Biogen price target raised to $245 from $236 at Wedbush
BMY Bristol-Myers
$66.06 /

+0.4 (+0.61%)

04/13/21 Truist
Bristol-Myers upgraded to Buy at Truist on improving pipeline asset visibility
04/13/21 Truist
Bristol-Myers upgraded to Buy from Hold at Truist
04/12/21 B. Riley
B. Riley calls Agenus the next Seagen, reiterates $8 target
03/08/21 BofA
Gartner added to US 1 List, Bristol-Myers removed at BofA
BHVN Biohaven Pharmaceutical
$73.50 /

+1.22 (+1.69%)

03/11/21
Fly Intel: Top five analyst initiations
03/11/21 UBS
Biohaven Pharmaceutical initiated with a Buy at UBS
03/02/21 Mizuho
Biohaven Pharmaceutical price target raised to $103 from $93 at Mizuho
CPRX Catalyst Pharmaceuticals
$4.39 /

+0.07 (+1.62%)

03/16/21 Piper Sandler
Catalyst business continues to generate cash flow, says Piper Sandler
01/07/21 Piper Sandler
Piper says Catalyst's Firdapse commercial business performing as expected
01/06/21 Piper Sandler
Catalyst Firdapse commercial business performing as expected, says Piper Sandler
11/10/20 Piper Sandler
Catalyst Pharmaceuticals price target lowered to $5.50 from $6 at Piper Sandler
DGX Quest Diagnostics
$129.37 /

-1.69 (-1.29%)

03/12/21 Baird
Quest Diagnostics downgraded to Neutral from Outperform at Baird
01/29/21 Citi
Quest Diagnostics price target raised to $158 from $151 at Citi
12/17/20 Morgan Stanley
Morgan Stanley cuts Quest Diagnostics to Equal Weight ahead of 2022 slowdown
12/17/20 Morgan Stanley
Quest Diagnostics downgraded to Equal Weight from Overweight at Morgan Stanley
DNA Bought by RHHBY
$94.97 /

+ (+0.00%)

HZNP Horizon Therapeutics
$91.07 /

+0.88 (+0.98%)

03/25/21 Guggenheim
Horizon Therapeutics price target raised to $120 from $115 at Guggenheim
03/22/21
Fly Intel: Top five analyst initiations
03/22/21 Morgan Stanley
Horizon Therapeutics resumed with an Overweight at Morgan Stanley
03/18/21 Citi
Horizon Therapeutics price target raised to $120 from $116 at Citi
LIVN LivaNova
$81.39 /

+0.74 (+0.92%)

04/19/21 Piper Sandler
LivaNova HF enrollment milestone a key step toward approval, says Piper Sandler
04/13/21 Piper Sandler
LivaNova price target raised to $92 from $81 at Piper Sandler
03/03/21
Fly Intel: Top five analyst downgrades
03/03/21 Berenberg
Berenberg cuts LivaNova EPS forecasts on investments, downgrades to Hold
LLY Eli Lilly
$190.55 /

+0.85 (+0.45%)

04/12/21 Benchmark
Benchmark sees full FDA approval of Regeneron's REGEN-COV coming
04/06/21 JPMorgan
JPMorgan survey 'broadly positive' on Eli Lilly Alzheimer's drug
03/24/21 BMO Capital
AbCellera price target lowered to $59 from $61 at BMO Capital
03/17/21 Mizuho
AbbVie's FDA request show Xeljanz concerns may bleed to Rinvoq, says Mizuho
MDT Medtronic
$128.29 /

+2.13 (+1.69%)

04/15/21 Atlantic Equities
Atlantic Equities starts Medtronic at Overweight
04/15/21 Atlantic Equities
Medtronic initiated with an Overweight at Atlantic Equities
04/05/21 Citi
Citi opens positive catalyst watches on four medical supply stocks
02/24/21 Cowen
Medtronic price target raised to $135 from $120 at Cowen
NVS Novartis
$87.84 /

-0.52 (-0.59%)

04/19/21 UBS
Novartis price target raised to CHF 96 from CHF 95 at UBS
04/05/21 Morgan Stanley
Regenxbio AAV9 patent challenged by Passage Bio, says Morgan Stanley
03/23/21 Societe Generale
Novartis price target raised to CHF 107 from CHF 104 at Societe Generale
03/22/21 Bernstein
Novartis initiated with a Market Perform at Bernstein
NVTA Invitae
$34.25 /

-1.08 (-3.06%)

04/05/21 Oppenheimer
Oppenheimer upgrades Invitae on valuation, sees potential high $50s stock
04/05/21 Oppenheimer
Invitae upgraded to Outperform from Perform at Oppenheimer
02/18/21 Ladenburg
Invitae upgraded to Buy with $58 price target at Ladenburg
02/18/21 Ladenburg
Invitae upgraded to Buy from Neutral at Ladenburg
PFE Pfizer
$39.03 /

+0.09 (+0.23%)

04/13/21 Morgan Stanley
Morgan Stanley says J&J news could improve 2022 outlook for mRNA vaccine makers
04/13/21 JPMorgan
Vaccine pause 'incremental negative' for J&J, says JPMorgan
04/09/21
Pfizer to host conference call
04/06/21 RBC Capital
Pfizer transferred with a Sector Perform at RBC Capital
PTCT PTC Therapeutics
$46.26 /

-1.27 (-2.67%)

03/29/21 RBC Capital
PTC Therapeutics upgraded to Sector Perform at RBC Capital on valuation
03/29/21 RBC Capital
PTC Therapeutics upgraded to Sector Perform from Underperform at RBC Capital
02/26/21 Cantor Fitzgerald
PTC Therapeutics price target lowered to $75 from $81 at Cantor Fitzgerald
02/12/21 BofA
PTC Therapeutics downgraded to Neutral from Buy at BofA
RETA Reata Pharmaceuticals
$89.28 /

-1.62 (-1.78%)

11/25/20 Citi
Reata Pharmaceuticals price target lowered to $234 from $260 at Citi
11/10/20 Cantor Fitzgerald
Reata Pharmaceuticals price target raised to $220 from $169 at Cantor Fitzgerald
11/10/20 Citi
Reata Pharmaceuticals price target raised to $260 from $244 at Citi
08/11/20 Cantor Fitzgerald
Reata Pharmaceuticals price target lowered to $169 from $275 at Cantor Fitzgerald
SNY Sanofi
$51.98 /

+0.12 (+0.23%)

04/06/21 Barclays
Sanofi price target raised to EUR 85 from EUR 80 at Barclays
02/23/21 BofA
BofA adds Heineken and IAG, removes Roche and Sanofi from Europe 1 list
02/10/21 Morgan Stanley
Sanofi price target raised to EUR 104 from EUR 101 at Morgan Stanley
02/05/21 Piper Sandler
Piper reiterates Overweight on Kymera after Sanofi capital markets day
SUPN Supernus
$30.69 /

-0.24 (-0.78%)

04/13/21 Jefferies
Supernus upgraded to Buy after survey work at Jefferies
04/13/21 Jefferies
Supernus upgraded to Buy from Hold at Jefferies
02/03/21 Piper Sandler
Supernus price target raised to $35 from $30 at Piper Sandler
06/16/20 Piper Sandler
Supernus upgraded to Overweight from Neutral at Piper Sandler
TAK Takeda Pharmaceutical
$16.84 /

-0.12 (-0.71%)

04/19/21 JPMorgan
Takeda Pharmaceutical downgraded to Neutral on R&D investments at JPMorgan
04/19/21 JPMorgan
Takeda Pharmaceutical downgraded to Neutral from Overweight at JPMorgan
04/15/21 Oppenheimer
Molecular Templates price target lowered to $13 from $18 at Oppenheimer
04/05/21
Fly Intel: Top five analyst downgrades
TEVA Teva
$10.12 /

-0.175 (-1.70%)

04/06/21 RBC Capital
Teva transferred with a Sector Perform at RBC Capital
01/26/21 Piper Sandler
Amarin in 'strong position' against Health Net, says Piper Sandler
12/21/20 Gabelli
Teva named 'Best Idea for 2021' at Gabelli
11/27/20 H.C. Wainwright
Corcept Therapeutics price target raised to $32 from $22 at H.C. Wainwright
TGTX TG Therapeutics
$39.95 /

-2.88 (-6.72%)

04/20/21
Fly Intel: Top five analyst initiations
04/20/21 Goldman Sachs
TG Therapeutics initiated with a Neutral at Goldman Sachs
04/19/21 Cantor Fitzgerald
TG Therapeutics price target raised to $74 from $68 at Cantor Fitzgerald
04/19/21 H.C. Wainwright
TG Therapeutics price target raised to $89 from $79 at H.C. Wainwright
ZGNX Zogenix
$18.79 /

-0.1 (-0.53%)

04/06/21 Evercore ISI
Evercore starts 'compelling' Arena spinoff Longboard at Outperform
04/06/21 Citi
Longboard Pharmaceuticals initiated with a Buy at Citi
02/03/21 Mizuho
Jazz deal for GW Pharma has positive read through to Zogenix, says Mizuho
12/04/20 Mizuho
Zogenix collaboration step in right direction, says Mizuho
AVDL Avadel Pharmaceuticals
$8.17 /

-0.3 (-3.54%)

03/10/21 H.C. Wainwright
Avadel Pharmaceuticals price target raised to $17 from $15 at H.C. Wainwright
01/25/21 Craig-Hallum
Avadel Pharmaceuticals assumed with a Buy rating at Craig-Hallum
08/28/20 Oppenheimer
Uwarranted pressure creates buying opportunity for Avadel, says Oppenheimer
08/28/20 SVB Leerink
Avadel selloff on Jazz competition worries overdone, says SVB Leerink
JNJ Johnson & Johnson
$166.47 /

+3.66 (+2.25%)

04/19/21 Chardan
Chardan sees J&J moving forward with Emergent if observations are minor
04/14/21 Guggenheim
Emergent BioSolutions price target lowered to $110 from $130 at Guggenheim
04/13/21 Goldman Sachs
J&J vaccine had numerical blood clot imbalance in trial, says Goldman Sachs
ZGNX Zogenix
$18.79 /

-0.1 (-0.53%)

TGTX TG Therapeutics
$39.95 /

-2.88 (-6.72%)

TEVA Teva
$10.12 /

-0.175 (-1.70%)

TAK Takeda Pharmaceutical
$16.84 /

-0.12 (-0.71%)

SUPN Supernus
$30.69 /

-0.24 (-0.78%)

SNY Sanofi
$51.98 /

+0.12 (+0.23%)

RETA Reata Pharmaceuticals
$89.28 /

-1.62 (-1.78%)

PTCT PTC Therapeutics
$46.26 /

-1.27 (-2.67%)

PFE Pfizer
$39.03 /

+0.09 (+0.23%)

NVTA Invitae
$34.25 /

-1.08 (-3.06%)

NVS Novartis
$87.84 /

-0.52 (-0.59%)

MDT Medtronic
$128.29 /

+2.13 (+1.69%)

LLY Eli Lilly
$190.55 /

+0.85 (+0.45%)

LIVN LivaNova
$81.39 /

+0.74 (+0.92%)

JNJ Johnson & Johnson
$166.47 /

+3.66 (+2.25%)

HZNP Horizon Therapeutics
$91.07 /

+0.88 (+0.98%)

DGX Quest Diagnostics
$129.37 /

-1.69 (-1.29%)

CPRX Catalyst Pharmaceuticals
$4.39 /

+0.07 (+1.62%)

BMY Bristol-Myers
$66.06 /

+0.4 (+0.61%)

BIIB Biogen
$272.95 /

+4.05 (+1.51%)

BHVN Biohaven Pharmaceutical
$73.50 /

+1.22 (+1.69%)

AVDL Avadel Pharmaceuticals
$8.17 /

-0.3 (-3.54%)

ALNY Alnylam
$135.74 /

-1.55 (-1.13%)

ACAD Acadia Pharmaceuticals
$20.79 /

+0.01 (+0.05%)

ABT Abbott
$120.00 /

-4.67 (-3.75%)

ABC AmerisourceBergen
$120.47 /

+0.98 (+0.82%)

ABBV AbbVie
$109.03 /

+0.43 (+0.40%)

  • 16
    Mar
  • 22
    Jan
  • 15
    Dec
  • 02
    Dec
  • 07
    Aug
  • 15
    May
  • 29
    Apr
TEVA Teva
$10.12 /

-0.175 (-1.70%)

SNY Sanofi
$51.98 /

+0.12 (+0.23%)

PFE Pfizer
$39.03 /

+0.09 (+0.23%)

NVS Novartis
$87.84 /

-0.52 (-0.59%)

LLY Eli Lilly
$190.55 /

+0.85 (+0.45%)

LIVN LivaNova
$81.39 /

+0.74 (+0.92%)

JNJ Johnson & Johnson
$166.47 /

+3.66 (+2.25%)

BMY Bristol-Myers
$66.06 /

+0.4 (+0.61%)

BIIB Biogen
$272.95 /

+4.05 (+1.51%)

ALNY Alnylam
$135.74 /

-1.55 (-1.13%)

ABT Abbott
$120.00 /

-4.67 (-3.75%)

ABC AmerisourceBergen
$120.47 /

+0.98 (+0.82%)

ABBV AbbVie
$109.03 /

+0.43 (+0.40%)

ZGNX Zogenix
$18.79 /

-0.1 (-0.53%)

TGTX TG Therapeutics
$39.95 /

-2.88 (-6.72%)

TEVA Teva
$10.12 /

-0.175 (-1.70%)

TAK Takeda Pharmaceutical
$16.84 /

-0.12 (-0.71%)

SUPN Supernus
$30.69 /

-0.24 (-0.78%)

SNY Sanofi
$51.98 /

+0.12 (+0.23%)

RETA Reata Pharmaceuticals
$89.28 /

-1.62 (-1.78%)

PTCT PTC Therapeutics
$46.26 /

-1.27 (-2.67%)

PFE Pfizer
$39.03 /

+0.09 (+0.23%)

NVTA Invitae
$34.25 /

-1.08 (-3.06%)

NVS Novartis
$87.84 /

-0.52 (-0.59%)

LLY Eli Lilly
$190.55 /

+0.85 (+0.45%)

JNJ Johnson & Johnson
$166.47 /

+3.66 (+2.25%)

HZNP Horizon Therapeutics
$91.07 /

+0.88 (+0.98%)

DGX Quest Diagnostics
$129.37 /

-1.69 (-1.29%)

CPRX Catalyst Pharmaceuticals
$4.39 /

+0.07 (+1.62%)

BMY Bristol-Myers
$66.06 /

+0.4 (+0.61%)

BIIB Biogen
$272.95 /

+4.05 (+1.51%)

BHVN Biohaven Pharmaceutical
$73.50 /

+1.22 (+1.69%)

AVDL Avadel Pharmaceuticals
$8.17 /

-0.3 (-3.54%)

ACAD Acadia Pharmaceuticals
$20.79 /

+0.01 (+0.05%)

ABT Abbott
$120.00 /

-4.67 (-3.75%)

ABC AmerisourceBergen
$120.47 /

+0.98 (+0.82%)

ABBV AbbVie
$109.03 /

+0.43 (+0.40%)

ZGNX Zogenix
$18.79 /

-0.1 (-0.53%)

TGTX TG Therapeutics
$39.95 /

-2.88 (-6.72%)

TEVA Teva
$10.12 /

-0.175 (-1.70%)

TAK Takeda Pharmaceutical
$16.84 /

-0.12 (-0.71%)

PFE Pfizer
$39.03 /

+0.09 (+0.23%)

NVTA Invitae
$34.25 /

-1.08 (-3.06%)

MDT Medtronic
$128.29 /

+2.13 (+1.69%)

LLY Eli Lilly
$190.55 /

+0.85 (+0.45%)

JNJ Johnson & Johnson
$166.47 /

+3.66 (+2.25%)

HZNP Horizon Therapeutics
$91.07 /

+0.88 (+0.98%)

DGX Quest Diagnostics
$129.37 /

-1.69 (-1.29%)

BMY Bristol-Myers
$66.06 /

+0.4 (+0.61%)

BIIB Biogen
$272.95 /

+4.05 (+1.51%)

ABT Abbott
$120.00 /

-4.67 (-3.75%)

ABC AmerisourceBergen
$120.47 /

+0.98 (+0.82%)

ABBV AbbVie
$109.03 /

+0.43 (+0.40%)

Tuesday
Downgrade
Fly Intel: Top five analyst downgrades » 09:58
04/20/21
04/20
09:58
04/20/21
09:58
NKE

Nike

$129.00 /

-3.58 (-2.70%)

, CAR

Avis Budget

$76.21 /

-2.04 (-2.61%)

, CLNE

Clean Energy

$10.92 /

-0.92 (-7.77%)

, STL

Sterling Bancorp

$23.64 /

-0.99 (-4.02%)

, OVID

Ovid Therapeutics

$3.43 /

-0.28 (-7.55%)

Catch up on today's…

Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Nike (NKE) downgraded to Neutral from Buy at Citi with analyst Paul Lejuez saying he believes in Nike's long-term growth and margin expansion story but he sees near-term pressures due to a slowdown in demand in China related to the Xinjiang cotton issue. 2. Avis Budget (CAR) downgraded to Neutral from Buy at BofA with analyst John Murphy saying he is adjusting his U.S. auto sales and North American auto production forecasts, effectively raising year-over-year growth forecasts for U.S. sales in 2021, but lowering 2022, while simultaneously lowering year-over-year growth forecasts for North American production in 2021, but raising 2022. 3. Clean Energy (CLNE) downgraded to Underperform from Market Perform at Raymond James with analyst Pavel Molchanov citing Clean Energy's announcement that it plans to supply fuel to a modest number of Amazon (AMZN) trucks, the latest instance of sentiment-driven multiple expansion with "minimal read-through" for profitability. 4. Sterling Bancorp (STL) downgraded to Neutral from Buy at Janney Montgomery and B. Riley following the merger with Webster Financial (WBS). 5. Ovid Therapeutics (OVID) downgraded to Neutral from Overweight at Cantor Fitzgerald with analyst Charles Duncan saying the downgrade is driven by a lack of visibility on early-stage programs entering the clinic that would result in value creating events. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

ShowHide Related Items >><<
STL Sterling Bancorp
$23.64 /

-0.99 (-4.02%)

OVID Ovid Therapeutics
$3.43 /

-0.28 (-7.55%)

NKE Nike
$129.00 /

-3.58 (-2.70%)

CLNE Clean Energy
$10.92 /

-0.92 (-7.77%)

CAR Avis Budget
$76.21 /

-2.04 (-2.61%)

NKE Nike
$129.00 /

-3.58 (-2.70%)

04/20/21 Citi
Nike downgraded to Neutral from Buy at Citi
03/31/21 HSBC
Nike price target raised to $162 from $158 at HSBC
03/30/21 Oppenheimer
Nike's China issues likely to resolve, says Oppenheimer
03/26/21
Fly Intel: Top five analyst upgrades
CAR Avis Budget
$76.21 /

-2.04 (-2.61%)

04/20/21 BofA
Avis Budget downgraded to Neutral from Buy at BofA
03/16/21
Fly Intel: Top five analyst downgrades
03/16/21 Morgan Stanley
Morgan Stanley downgrades Avis Budget to Equal Weight, sees recovery priced in
03/15/21 Morgan Stanley
Avis Budget downgraded to Equal Weight from Overweight at Morgan Stanley
CLNE Clean Energy
$10.92 /

-0.92 (-7.77%)

04/20/21 Lake Street
Clean Energy deal with Amazon 'a watershed moment,' says Lake Street
04/20/21 Raymond James
Clean Energy downgraded to Underperform from Market Perform at Raymond James
04/20/21 Raymond James
Clean Energy downgraded to Underperform from Market Perform at Raymond James
03/26/21 Cowen
Clean Energy transitions to gas production, Cowen starts with Market Perform
STL Sterling Bancorp
$23.64 /

-0.99 (-4.02%)

04/20/21 B. Riley
Sterling Bancorp downgraded to Neutral from Buy at B. Riley
04/20/21 Maxim
Sterling Bancorp price target raised to $30 from $24 at Maxim
04/20/21 Raymond James
Webster Financial downgraded to Outperform from Strong Buy at Raymond James
04/19/21 Janney Montgomery Scott
Sterling Bancorp downgraded to Neutral from Buy at Janney Montgomery
OVID Ovid Therapeutics
$3.43 /

-0.28 (-7.55%)

04/20/21 Cantor Fitzgerald
Ovid Therapeutics downgraded to Neutral from Overweight at Cantor Fitzgerald
03/04/21 Citi
Ovid Therapeutics price target raised to $5 from $4 at Citi
03/03/21 RBC Capital
Ovid downgraded to Sector Perform at RBC Capital after rally on Takeda deal
03/03/21 RBC Capital
Ovid Therapeutics downgraded to Sector Perform from Outperform at RBC Capital
STL Sterling Bancorp
$23.64 /

-0.99 (-4.02%)

OVID Ovid Therapeutics
$3.43 /

-0.28 (-7.55%)

NKE Nike
$129.00 /

-3.58 (-2.70%)

CLNE Clean Energy
$10.92 /

-0.92 (-7.77%)

CAR Avis Budget
$76.21 /

-2.04 (-2.61%)

  • 25
    Aug
NKE Nike
$129.00 /

-3.58 (-2.70%)

CLNE Clean Energy
$10.92 /

-0.92 (-7.77%)

STL Sterling Bancorp
$23.64 /

-0.99 (-4.02%)

OVID Ovid Therapeutics
$3.43 /

-0.28 (-7.55%)

NKE Nike
$129.00 /

-3.58 (-2.70%)

CLNE Clean Energy
$10.92 /

-0.92 (-7.77%)

CAR Avis Budget
$76.21 /

-2.04 (-2.61%)

OVID Ovid Therapeutics
$3.43 /

-0.28 (-7.55%)

NKE Nike
$129.00 /

-3.58 (-2.70%)

CLNE Clean Energy
$10.92 /

-0.92 (-7.77%)

CAR Avis Budget
$76.21 /

-2.04 (-2.61%)

Hot Stocks
Ovid Therapeutics appoints Robert Langer as chair of SAB » 08:11
04/20/21
04/20
08:11
04/20/21
08:11
OVID

Ovid Therapeutics

$3.71 /

-0.075 (-1.98%)

Ovid Therapeutics…

Ovid Therapeutics announced that it has appointed Professor Robert S. Langer, Sc.D., as Chairman of its Scientific Advisory Board. Langer is one of 10 Institute Professors at the Massachusetts Institute of Technology, and has written over 1,500 scholarly articles.

ShowHide Related Items >><<
OVID Ovid Therapeutics
$3.71 /

-0.075 (-1.98%)

OVID Ovid Therapeutics
$3.71 /

-0.075 (-1.98%)

04/20/21 Cantor Fitzgerald
Ovid Therapeutics downgraded to Neutral from Overweight at Cantor Fitzgerald
03/04/21 Citi
Ovid Therapeutics price target raised to $5 from $4 at Citi
03/03/21 RBC Capital
Ovid downgraded to Sector Perform at RBC Capital after rally on Takeda deal
03/03/21 RBC Capital
Ovid Therapeutics downgraded to Sector Perform from Outperform at RBC Capital
OVID Ovid Therapeutics
$3.71 /

-0.075 (-1.98%)

  • 25
    Aug
OVID Ovid Therapeutics
$3.71 /

-0.075 (-1.98%)

OVID Ovid Therapeutics
$3.71 /

-0.075 (-1.98%)

Downgrade
Ovid Therapeutics downgraded to Neutral from Overweight at Cantor Fitzgerald » 07:23
04/20/21
04/20
07:23
04/20/21
07:23
OVID

Ovid Therapeutics

$3.71 /

-0.075 (-1.98%)

Cantor Fitzgerald analyst…

Cantor Fitzgerald analyst Charles Duncan downgraded Ovid Therapeutics to Neutral from Overweight with a price target of $4, down from $8, after Ovid announced that it will discontinue development of OV101 in Angelman syndrome and does not plan to initiate further clinical studies of '101 in fragile X syndrome. The downgrade is driven by a lack of visibility on early-stage programs entering the clinic that would result in value creating events, Duncan tells investors in a research note.

ShowHide Related Items >><<
OVID Ovid Therapeutics
$3.71 /

-0.075 (-1.98%)

OVID Ovid Therapeutics
$3.71 /

-0.075 (-1.98%)

03/04/21 Citi
Ovid Therapeutics price target raised to $5 from $4 at Citi
03/03/21 RBC Capital
Ovid downgraded to Sector Perform at RBC Capital after rally on Takeda deal
03/03/21 RBC Capital
Ovid Therapeutics downgraded to Sector Perform from Outperform at RBC Capital
12/02/20 RBC Capital
Ovid Therapeutics price target lowered to $5 from $17 at RBC Capital
OVID Ovid Therapeutics
$3.71 /

-0.075 (-1.98%)

  • 25
    Aug
OVID Ovid Therapeutics
$3.71 /

-0.075 (-1.98%)

OVID Ovid Therapeutics
$3.71 /

-0.075 (-1.98%)

Conference/Events
American Academy of Neurology to hold a virtual meeting » 04:55
04/20/21
04/20
04:55
04/20/21
04:55
ABBV

AbbVie

$108.66 /

+0.73 (+0.68%)

, ABC

AmerisourceBergen

$119.49 /

-0.02 (-0.02%)

, ABT

Abbott

$124.67 /

+0.3 (+0.24%)

, ACAD

Acadia Pharmaceuticals

$20.78 /

-0.39 (-1.84%)

, ALNY

Alnylam

$137.25 /

-1.535 (-1.11%)

, BIIB

Biogen

$268.99 /

-1.23 (-0.46%)

, BMY

Bristol-Myers

$65.66 /

+0.2 (+0.31%)

, BHVN

Biohaven Pharmaceutical

$72.23 /

-2.135 (-2.87%)

, CPRX

Catalyst Pharmaceuticals

$4.32 /

-0.115 (-2.59%)

, DGX

Quest Diagnostics

$130.97 /

+0.86 (+0.66%)

, DNA

Bought by RHHBY

$94.97 /

+ (+0.00%)

, HZNP

Horizon Therapeutics

$90.26 /

-3.06 (-3.28%)

, LIVN

LivaNova

$80.65 /

-0.7 (-0.86%)

, LLY

Eli Lilly

$189.86 /

+0.58 (+0.31%)

, MDT

Medtronic

$126.16 /

+0.25 (+0.20%)

, NVS

Novartis

$88.36 /

+0.335 (+0.38%)

, NVTA

Invitae

$35.34 /

-2.31 (-6.14%)

, PFE

Pfizer

$38.94 /

+0.37 (+0.96%)

, PTCT

PTC Therapeutics

$47.53 /

-1.01 (-2.08%)

, RETA

Reata Pharmaceuticals

$91.38 /

+0.55 (+0.61%)

, SNY

Sanofi

$51.86 /

+0.56 (+1.09%)

, SUPN

Supernus

$30.93 /

-0.82 (-2.58%)

, TAK

Takeda Pharmaceutical

$16.95 /

-0.115 (-0.67%)

, TEVA

Teva

$10.29 /

-0.46 (-4.28%)

, TGTX

TG Therapeutics

$42.83 /

-1.88 (-4.20%)

, ZGNX

Zogenix

$18.89 /

-0.1 (-0.53%)

, AVDL

Avadel Pharmaceuticals

$8.47 /

-0.18 (-2.08%)

, JNJ

Johnson & Johnson

$162.98 /

+0.83 (+0.51%)

73rd Annual Virtual…

73rd Annual Virtual Meeting of AAN will be held on April 17-22. Webcast Link

ShowHide Related Items >><<
ZGNX Zogenix
$18.89 /

-0.1 (-0.53%)

TGTX TG Therapeutics
$42.83 /

-1.88 (-4.20%)

TEVA Teva
$10.29 /

-0.46 (-4.28%)

TAK Takeda Pharmaceutical
$16.95 /

-0.115 (-0.67%)

SUPN Supernus
$30.93 /

-0.82 (-2.58%)

SNY Sanofi
$51.86 /

+0.56 (+1.09%)

RETA Reata Pharmaceuticals
$91.38 /

+0.55 (+0.61%)

PTCT PTC Therapeutics
$47.53 /

-1.01 (-2.08%)

PFE Pfizer
$38.94 /

+0.37 (+0.96%)

NVTA Invitae
$35.34 /

-2.31 (-6.14%)

NVS Novartis
$88.36 /

+0.335 (+0.38%)

MDT Medtronic
$126.16 /

+0.25 (+0.20%)

LLY Eli Lilly
$189.86 /

+0.58 (+0.31%)

LIVN LivaNova
$80.65 /

-0.7 (-0.86%)

JNJ Johnson & Johnson
$162.98 /

+0.83 (+0.51%)

HZNP Horizon Therapeutics
$90.26 /

-3.06 (-3.28%)

DGX Quest Diagnostics
$130.97 /

+0.86 (+0.66%)

CPRX Catalyst Pharmaceuticals
$4.32 /

-0.115 (-2.59%)

BMY Bristol-Myers
$65.66 /

+0.2 (+0.31%)

BIIB Biogen
$268.99 /

-1.23 (-0.46%)

BHVN Biohaven Pharmaceutical
$72.23 /

-2.135 (-2.87%)

AVDL Avadel Pharmaceuticals
$8.47 /

-0.18 (-2.08%)

ALNY Alnylam
$137.25 /

-1.535 (-1.11%)

ACAD Acadia Pharmaceuticals
$20.78 /

-0.39 (-1.84%)

ABT Abbott
$124.67 /

+0.3 (+0.24%)

ABC AmerisourceBergen
$119.49 /

-0.02 (-0.02%)

ABBV AbbVie
$108.66 /

+0.73 (+0.68%)

ABBV AbbVie
$108.66 /

+0.73 (+0.68%)

04/06/21 RBC Capital
AbbVie transferred with an Outperform at RBC Capital
04/01/21 Piper Sandler
Integra to benefit from FDA safety communication, says Piper Sandler
04/01/21 Piper Sandler
Piper migraine survey bearish for Amgen, bullish for Biohaven
03/17/21 JPMorgan
AbbVie selloff on Rinvoq deal 'appears overdone,' says JPMorgan
ABC AmerisourceBergen
$119.49 /

-0.02 (-0.02%)

03/09/21 Baird
AmerisourceBergen remains top pick following results, says Baird
02/09/21 Mizuho
AmerisourceBergen price target raised to $114 from $104 at Mizuho
02/08/21 Cowen
AmerisourceBergen price target raised to $150 from $145 at Cowen
02/04/21 Evercore ISI
AmerisourceBergen upgraded to Outperform after Q1 report at Evercore ISI
ABT Abbott
$124.67 /

+0.3 (+0.24%)

04/15/21 Atlantic Equities
Atlantic Equities starts Abbott at Neutral
04/15/21 Atlantic Equities
Abbott initiated with a Neutral at Atlantic Equities
03/16/21 Piper Sandler
Abbott study challenging Abiomed's Impella halted, says Piper Sandler
03/10/21 Wells Fargo
Wells says Quidel Covid testing comments not a direct read through to Abbott
ACAD Acadia Pharmaceuticals
$20.78 /

-0.39 (-1.84%)

04/07/21 Needham
Acadia price target lowered to $30 from $44 at Needham
04/07/21 H.C. Wainwright
Acadia downgraded to Neutral from Buy at H.C. Wainwright
04/06/21 SVB Leerink
Acadia price target lowered to $31 from $63 at SVB Leerink
04/06/21 Jefferies
Acadia downgraded to Hold at Jefferies after dementia-related psychosis CRL
ALNY Alnylam
$137.25 /

-1.535 (-1.11%)

02/22/21 Guggenheim
Alnylam downgraded to Neutral from Buy at Guggenheim
02/12/21
Fly Intel: Top five analyst downgrades
02/12/21 Barclays
Alnylam price target raised to $196 from $162 at Barclays
02/12/21 Citi
Alnylam downgraded to Neutral from Buy at Citi
BIIB Biogen
$268.99 /

-1.23 (-0.46%)

04/19/21 Jefferies
Biogen 'may have best risk/reward among large caps' in 2021-23, says Jefferies
04/13/21 Roth Capital
Roth Capital sees Applied Genetic's XLRS licensing as vote of confidence
04/12/21 Oppenheimer
Sage Therapeutics data support 'enthusiasm' for SAGE-324 in ET, says Oppenheimer
04/12/21 Wedbush
Biogen price target raised to $245 from $236 at Wedbush
BMY Bristol-Myers
$65.66 /

+0.2 (+0.31%)

04/13/21 Truist
Bristol-Myers upgraded to Buy at Truist on improving pipeline asset visibility
04/13/21 Truist
Bristol-Myers upgraded to Buy from Hold at Truist
04/12/21 B. Riley
B. Riley calls Agenus the next Seagen, reiterates $8 target
03/08/21 BofA
Gartner added to US 1 List, Bristol-Myers removed at BofA
BHVN Biohaven Pharmaceutical
$72.23 /

-2.135 (-2.87%)

03/11/21
Fly Intel: Top five analyst initiations
03/11/21 UBS
Biohaven Pharmaceutical initiated with a Buy at UBS
03/02/21 Mizuho
Biohaven Pharmaceutical price target raised to $103 from $93 at Mizuho
CPRX Catalyst Pharmaceuticals
$4.32 /

-0.115 (-2.59%)

03/16/21 Piper Sandler
Catalyst business continues to generate cash flow, says Piper Sandler
01/07/21 Piper Sandler
Piper says Catalyst's Firdapse commercial business performing as expected
01/06/21 Piper Sandler
Catalyst Firdapse commercial business performing as expected, says Piper Sandler
11/10/20 Piper Sandler
Catalyst Pharmaceuticals price target lowered to $5.50 from $6 at Piper Sandler
DGX Quest Diagnostics
$130.97 /

+0.86 (+0.66%)

03/12/21 Baird
Quest Diagnostics downgraded to Neutral from Outperform at Baird
01/29/21 Citi
Quest Diagnostics price target raised to $158 from $151 at Citi
12/17/20 Morgan Stanley
Morgan Stanley cuts Quest Diagnostics to Equal Weight ahead of 2022 slowdown
12/17/20 Morgan Stanley
Quest Diagnostics downgraded to Equal Weight from Overweight at Morgan Stanley
DNA Bought by RHHBY
$94.97 /

+ (+0.00%)

HZNP Horizon Therapeutics
$90.26 /

-3.06 (-3.28%)

03/25/21 Guggenheim
Horizon Therapeutics price target raised to $120 from $115 at Guggenheim
03/22/21
Fly Intel: Top five analyst initiations
03/22/21 Morgan Stanley
Horizon Therapeutics resumed with an Overweight at Morgan Stanley
03/18/21 Citi
Horizon Therapeutics price target raised to $120 from $116 at Citi
LIVN LivaNova
$80.65 /

-0.7 (-0.86%)

04/19/21 Piper Sandler
LivaNova HF enrollment milestone a key step toward approval, says Piper Sandler
04/13/21 Piper Sandler
LivaNova price target raised to $92 from $81 at Piper Sandler
03/03/21
Fly Intel: Top five analyst downgrades
03/03/21 Berenberg
Berenberg cuts LivaNova EPS forecasts on investments, downgrades to Hold
LLY Eli Lilly
$189.86 /

+0.58 (+0.31%)

04/12/21 Benchmark
Benchmark sees full FDA approval of Regeneron's REGEN-COV coming
04/06/21 JPMorgan
JPMorgan survey 'broadly positive' on Eli Lilly Alzheimer's drug
03/24/21 BMO Capital
AbCellera price target lowered to $59 from $61 at BMO Capital
03/17/21 Mizuho
AbbVie's FDA request show Xeljanz concerns may bleed to Rinvoq, says Mizuho
MDT Medtronic
$126.16 /

+0.25 (+0.20%)

04/15/21 Atlantic Equities
Atlantic Equities starts Medtronic at Overweight
04/15/21 Atlantic Equities
Medtronic initiated with an Overweight at Atlantic Equities
04/05/21 Citi
Citi opens positive catalyst watches on four medical supply stocks
02/24/21 Cowen
Medtronic price target raised to $135 from $120 at Cowen
NVS Novartis
$88.36 /

+0.335 (+0.38%)

04/19/21 UBS
Novartis price target raised to CHF 96 from CHF 95 at UBS
04/05/21 Morgan Stanley
Regenxbio AAV9 patent challenged by Passage Bio, says Morgan Stanley
03/23/21 Societe Generale
Novartis price target raised to CHF 107 from CHF 104 at Societe Generale
03/22/21 Bernstein
Novartis initiated with a Market Perform at Bernstein
NVTA Invitae
$35.34 /

-2.31 (-6.14%)

04/05/21 Oppenheimer
Oppenheimer upgrades Invitae on valuation, sees potential high $50s stock
04/05/21 Oppenheimer
Invitae upgraded to Outperform from Perform at Oppenheimer
02/18/21 Ladenburg
Invitae upgraded to Buy with $58 price target at Ladenburg
02/18/21 Ladenburg
Invitae upgraded to Buy from Neutral at Ladenburg
PFE Pfizer
$38.94 /

+0.37 (+0.96%)

04/13/21 Morgan Stanley
Morgan Stanley says J&J news could improve 2022 outlook for mRNA vaccine makers
04/13/21 JPMorgan
Vaccine pause 'incremental negative' for J&J, says JPMorgan
04/09/21
Pfizer to host conference call
04/06/21 RBC Capital
Pfizer transferred with a Sector Perform at RBC Capital
PTCT PTC Therapeutics
$47.53 /

-1.01 (-2.08%)

03/29/21 RBC Capital
PTC Therapeutics upgraded to Sector Perform at RBC Capital on valuation
03/29/21 RBC Capital
PTC Therapeutics upgraded to Sector Perform from Underperform at RBC Capital
02/26/21 Cantor Fitzgerald
PTC Therapeutics price target lowered to $75 from $81 at Cantor Fitzgerald
02/12/21 BofA
PTC Therapeutics downgraded to Neutral from Buy at BofA
RETA Reata Pharmaceuticals
$91.38 /

+0.55 (+0.61%)

11/25/20 Citi
Reata Pharmaceuticals price target lowered to $234 from $260 at Citi
11/10/20 Cantor Fitzgerald
Reata Pharmaceuticals price target raised to $220 from $169 at Cantor Fitzgerald
11/10/20 Citi
Reata Pharmaceuticals price target raised to $260 from $244 at Citi
08/11/20 Cantor Fitzgerald
Reata Pharmaceuticals price target lowered to $169 from $275 at Cantor Fitzgerald
SNY Sanofi
$51.86 /

+0.56 (+1.09%)

04/06/21 Barclays
Sanofi price target raised to EUR 85 from EUR 80 at Barclays
02/23/21 BofA
BofA adds Heineken and IAG, removes Roche and Sanofi from Europe 1 list
02/10/21 Morgan Stanley
Sanofi price target raised to EUR 104 from EUR 101 at Morgan Stanley
02/05/21 Piper Sandler
Piper reiterates Overweight on Kymera after Sanofi capital markets day
SUPN Supernus
$30.93 /

-0.82 (-2.58%)

04/13/21 Jefferies
Supernus upgraded to Buy after survey work at Jefferies
04/13/21 Jefferies
Supernus upgraded to Buy from Hold at Jefferies
02/03/21 Piper Sandler
Supernus price target raised to $35 from $30 at Piper Sandler
06/16/20 Piper Sandler
Supernus upgraded to Overweight from Neutral at Piper Sandler
TAK Takeda Pharmaceutical
$16.95 /

-0.115 (-0.67%)

04/19/21 JPMorgan
Takeda Pharmaceutical downgraded to Neutral on R&D investments at JPMorgan
04/19/21 JPMorgan
Takeda Pharmaceutical downgraded to Neutral from Overweight at JPMorgan
04/15/21 Oppenheimer
Molecular Templates price target lowered to $13 from $18 at Oppenheimer
04/05/21
Fly Intel: Top five analyst downgrades
TEVA Teva
$10.29 /

-0.46 (-4.28%)

04/06/21 RBC Capital
Teva transferred with a Sector Perform at RBC Capital
01/26/21 Piper Sandler
Amarin in 'strong position' against Health Net, says Piper Sandler
12/21/20 Gabelli
Teva named 'Best Idea for 2021' at Gabelli
11/27/20 H.C. Wainwright
Corcept Therapeutics price target raised to $32 from $22 at H.C. Wainwright
TGTX TG Therapeutics
$42.83 /

-1.88 (-4.20%)

04/19/21 Cantor Fitzgerald
TG Therapeutics price target raised to $74 from $68 at Cantor Fitzgerald
04/19/21 H.C. Wainwright
TG Therapeutics price target raised to $89 from $79 at H.C. Wainwright
03/04/21 B. Riley
TG Therapeutics price target lowered to $91 from $95 at B. Riley Securities
02/09/21 B. Riley
TG Therapeutics price target raised to $95 from $90 at B. Riley Securities
ZGNX Zogenix
$18.89 /

-0.1 (-0.53%)

04/06/21 Evercore ISI
Evercore starts 'compelling' Arena spinoff Longboard at Outperform
04/06/21 Citi
Longboard Pharmaceuticals initiated with a Buy at Citi
02/03/21 Mizuho
Jazz deal for GW Pharma has positive read through to Zogenix, says Mizuho
12/04/20 Mizuho
Zogenix collaboration step in right direction, says Mizuho
AVDL Avadel Pharmaceuticals
$8.47 /

-0.18 (-2.08%)

03/10/21 H.C. Wainwright
Avadel Pharmaceuticals price target raised to $17 from $15 at H.C. Wainwright
01/25/21 Craig-Hallum
Avadel Pharmaceuticals assumed with a Buy rating at Craig-Hallum
08/28/20 Oppenheimer
Uwarranted pressure creates buying opportunity for Avadel, says Oppenheimer
08/28/20 SVB Leerink
Avadel selloff on Jazz competition worries overdone, says SVB Leerink
JNJ Johnson & Johnson
$162.98 /

+0.83 (+0.51%)

04/19/21 Chardan
Chardan sees J&J moving forward with Emergent if observations are minor
04/14/21 Guggenheim
Emergent BioSolutions price target lowered to $110 from $130 at Guggenheim
04/13/21 Goldman Sachs
J&J vaccine had numerical blood clot imbalance in trial, says Goldman Sachs
ZGNX Zogenix
$18.89 /

-0.1 (-0.53%)

TGTX TG Therapeutics
$42.83 /

-1.88 (-4.20%)

TEVA Teva
$10.29 /

-0.46 (-4.28%)

TAK Takeda Pharmaceutical
$16.95 /

-0.115 (-0.67%)

SUPN Supernus
$30.93 /

-0.82 (-2.58%)

SNY Sanofi
$51.86 /

+0.56 (+1.09%)

RETA Reata Pharmaceuticals
$91.38 /

+0.55 (+0.61%)

PTCT PTC Therapeutics
$47.53 /

-1.01 (-2.08%)

PFE Pfizer
$38.94 /

+0.37 (+0.96%)

NVTA Invitae
$35.34 /

-2.31 (-6.14%)

NVS Novartis
$88.36 /

+0.335 (+0.38%)

MDT Medtronic
$126.16 /

+0.25 (+0.20%)

LLY Eli Lilly
$189.86 /

+0.58 (+0.31%)

LIVN LivaNova
$80.65 /

-0.7 (-0.86%)

JNJ Johnson & Johnson
$162.98 /

+0.83 (+0.51%)

HZNP Horizon Therapeutics
$90.26 /

-3.06 (-3.28%)

DGX Quest Diagnostics
$130.97 /

+0.86 (+0.66%)

CPRX Catalyst Pharmaceuticals
$4.32 /

-0.115 (-2.59%)

BMY Bristol-Myers
$65.66 /

+0.2 (+0.31%)

BIIB Biogen
$268.99 /

-1.23 (-0.46%)

BHVN Biohaven Pharmaceutical
$72.23 /

-2.135 (-2.87%)

AVDL Avadel Pharmaceuticals
$8.47 /

-0.18 (-2.08%)

ALNY Alnylam
$137.25 /

-1.535 (-1.11%)

ACAD Acadia Pharmaceuticals
$20.78 /

-0.39 (-1.84%)

ABT Abbott
$124.67 /

+0.3 (+0.24%)

ABC AmerisourceBergen
$119.49 /

-0.02 (-0.02%)

ABBV AbbVie
$108.66 /

+0.73 (+0.68%)

  • 16
    Mar
  • 22
    Jan
  • 15
    Dec
  • 02
    Dec
  • 07
    Aug
  • 15
    May
  • 29
    Apr
TEVA Teva
$10.29 /

-0.46 (-4.28%)

SNY Sanofi
$51.86 /

+0.56 (+1.09%)

PFE Pfizer
$38.94 /

+0.37 (+0.96%)

NVS Novartis
$88.36 /

+0.335 (+0.38%)

LLY Eli Lilly
$189.86 /

+0.58 (+0.31%)

LIVN LivaNova
$80.65 /

-0.7 (-0.86%)

JNJ Johnson & Johnson
$162.98 /

+0.83 (+0.51%)

BMY Bristol-Myers
$65.66 /

+0.2 (+0.31%)

BIIB Biogen
$268.99 /

-1.23 (-0.46%)

ALNY Alnylam
$137.25 /

-1.535 (-1.11%)

ABT Abbott
$124.67 /

+0.3 (+0.24%)

ABC AmerisourceBergen
$119.49 /

-0.02 (-0.02%)

ABBV AbbVie
$108.66 /

+0.73 (+0.68%)

ZGNX Zogenix
$18.89 /

-0.1 (-0.53%)

TGTX TG Therapeutics
$42.83 /

-1.88 (-4.20%)

TEVA Teva
$10.29 /

-0.46 (-4.28%)

TAK Takeda Pharmaceutical
$16.95 /

-0.115 (-0.67%)

SUPN Supernus
$30.93 /

-0.82 (-2.58%)

SNY Sanofi
$51.86 /

+0.56 (+1.09%)

RETA Reata Pharmaceuticals
$91.38 /

+0.55 (+0.61%)

PTCT PTC Therapeutics
$47.53 /

-1.01 (-2.08%)

PFE Pfizer
$38.94 /

+0.37 (+0.96%)

NVTA Invitae
$35.34 /

-2.31 (-6.14%)

NVS Novartis
$88.36 /

+0.335 (+0.38%)

LLY Eli Lilly
$189.86 /

+0.58 (+0.31%)

JNJ Johnson & Johnson
$162.98 /

+0.83 (+0.51%)

HZNP Horizon Therapeutics
$90.26 /

-3.06 (-3.28%)

DGX Quest Diagnostics
$130.97 /

+0.86 (+0.66%)

CPRX Catalyst Pharmaceuticals
$4.32 /

-0.115 (-2.59%)

BMY Bristol-Myers
$65.66 /

+0.2 (+0.31%)

BIIB Biogen
$268.99 /

-1.23 (-0.46%)

BHVN Biohaven Pharmaceutical
$72.23 /

-2.135 (-2.87%)

AVDL Avadel Pharmaceuticals
$8.47 /

-0.18 (-2.08%)

ACAD Acadia Pharmaceuticals
$20.78 /

-0.39 (-1.84%)

ABT Abbott
$124.67 /

+0.3 (+0.24%)

ABC AmerisourceBergen
$119.49 /

-0.02 (-0.02%)

ABBV AbbVie
$108.66 /

+0.73 (+0.68%)

ZGNX Zogenix
$18.89 /

-0.1 (-0.53%)

TGTX TG Therapeutics
$42.83 /

-1.88 (-4.20%)

TEVA Teva
$10.29 /

-0.46 (-4.28%)

TAK Takeda Pharmaceutical
$16.95 /

-0.115 (-0.67%)

PFE Pfizer
$38.94 /

+0.37 (+0.96%)

NVTA Invitae
$35.34 /

-2.31 (-6.14%)

MDT Medtronic
$126.16 /

+0.25 (+0.20%)

LLY Eli Lilly
$189.86 /

+0.58 (+0.31%)

JNJ Johnson & Johnson
$162.98 /

+0.83 (+0.51%)

HZNP Horizon Therapeutics
$90.26 /

-3.06 (-3.28%)

DGX Quest Diagnostics
$130.97 /

+0.86 (+0.66%)

BMY Bristol-Myers
$65.66 /

+0.2 (+0.31%)

BIIB Biogen
$268.99 /

-1.23 (-0.46%)

ABT Abbott
$124.67 /

+0.3 (+0.24%)

ABC AmerisourceBergen
$119.49 /

-0.02 (-0.02%)

ABBV AbbVie
$108.66 /

+0.73 (+0.68%)

Monday
Conference/Events
American Academy of Neurology to hold a virtual meeting » 09:24
04/19/21
04/19
09:24
04/19/21
09:24
ABBV

AbbVie

$107.93 /

+1.05 (+0.98%)

, ABC

AmerisourceBergen

$119.62 /

+0.55 (+0.46%)

, ABT

Abbott

$124.37 /

+0.4 (+0.32%)

, ACAD

Acadia Pharmaceuticals

$21.17 /

-0.02 (-0.09%)

, ALNY

Alnylam

$138.69 /

-0.23 (-0.17%)

, BIIB

Biogen

$270.07 /

-0.66 (-0.24%)

, BMY

Bristol-Myers

$65.46 /

+1.02 (+1.58%)

, BHVN

Biohaven Pharmaceutical

$74.37 /

-1.435 (-1.89%)

, CPRX

Catalyst Pharmaceuticals

$4.44 /

-0.02 (-0.45%)

, DGX

Quest Diagnostics

$130.09 /

+0.86 (+0.67%)

, DNA

Bought by RHHBY

$94.97 /

+ (+0.00%)

, HZNP

Horizon Therapeutics

$93.25 /

-0.32 (-0.34%)

, LIVN

LivaNova

$81.37 /

-1.46 (-1.76%)

, LLY

Eli Lilly

$189.25 /

+3.28 (+1.76%)

, MDT

Medtronic

$125.91 /

+0.06 (+0.05%)

, NVS

Novartis

$88.02 /

+0.81 (+0.93%)

, NVTA

Invitae

$37.65 /

-1.47 (-3.76%)

, PFE

Pfizer

$38.57 /

+0.96 (+2.55%)

, PTCT

PTC Therapeutics

$48.48 /

+0.33 (+0.69%)

, RETA

Reata Pharmaceuticals

$90.83 /

-1.29 (-1.40%)

, SNY

Sanofi

$51.29 /

+0.63 (+1.24%)

, SUPN

Supernus

$31.72 /

-0.09 (-0.28%)

, TAK

Takeda Pharmaceutical

$17.08 /

-0.13 (-0.76%)

, TEVA

Teva

$10.75 /

-0.08 (-0.74%)

, TGTX

TG Therapeutics

$44.79 /

-1.05 (-2.29%)

, ZGNX

Zogenix

$19.00 /

-0.65 (-3.31%)

, AVDL

Avadel Pharmaceuticals

$8.65 /

+0.09 (+1.05%)

, JNJ

Johnson & Johnson

$162.24 /

+1.74 (+1.08%)

73rd Annual Virtual…

73rd Annual Virtual Meeting of AAN will be held on April 17-22. Webcast Link

ShowHide Related Items >><<
ZGNX Zogenix
$19.00 /

-0.65 (-3.31%)

TGTX TG Therapeutics
$44.79 /

-1.05 (-2.29%)

TEVA Teva
$10.75 /

-0.08 (-0.74%)

TAK Takeda Pharmaceutical
$17.08 /

-0.13 (-0.76%)

SUPN Supernus
$31.72 /

-0.09 (-0.28%)

SNY Sanofi
$51.29 /

+0.63 (+1.24%)

RETA Reata Pharmaceuticals
$90.83 /

-1.29 (-1.40%)

PTCT PTC Therapeutics
$48.48 /

+0.33 (+0.69%)

PFE Pfizer
$38.57 /

+0.96 (+2.55%)

NVTA Invitae
$37.65 /

-1.47 (-3.76%)

NVS Novartis
$88.02 /

+0.81 (+0.93%)

MDT Medtronic
$125.91 /

+0.06 (+0.05%)

LLY Eli Lilly
$189.25 /

+3.28 (+1.76%)

LIVN LivaNova
$81.37 /

-1.46 (-1.76%)

JNJ Johnson & Johnson
$162.24 /

+1.74 (+1.08%)

HZNP Horizon Therapeutics
$93.25 /

-0.32 (-0.34%)

DGX Quest Diagnostics
$130.09 /

+0.86 (+0.67%)

CPRX Catalyst Pharmaceuticals
$4.44 /

-0.02 (-0.45%)

BMY Bristol-Myers
$65.46 /

+1.02 (+1.58%)

BIIB Biogen
$270.07 /

-0.66 (-0.24%)

BHVN Biohaven Pharmaceutical
$74.37 /

-1.435 (-1.89%)

AVDL Avadel Pharmaceuticals
$8.65 /

+0.09 (+1.05%)

ALNY Alnylam
$138.69 /

-0.23 (-0.17%)

ACAD Acadia Pharmaceuticals
$21.17 /

-0.02 (-0.09%)

ABT Abbott
$124.37 /

+0.4 (+0.32%)

ABC AmerisourceBergen
$119.62 /

+0.55 (+0.46%)

ABBV AbbVie
$107.93 /

+1.05 (+0.98%)

ABBV AbbVie
$107.93 /

+1.05 (+0.98%)

04/06/21 RBC Capital
AbbVie transferred with an Outperform at RBC Capital
04/01/21 Piper Sandler
Integra to benefit from FDA safety communication, says Piper Sandler
04/01/21 Piper Sandler
Piper migraine survey bearish for Amgen, bullish for Biohaven
03/17/21 JPMorgan
AbbVie selloff on Rinvoq deal 'appears overdone,' says JPMorgan
ABC AmerisourceBergen
$119.62 /

+0.55 (+0.46%)

03/09/21 Baird
AmerisourceBergen remains top pick following results, says Baird
02/09/21 Mizuho
AmerisourceBergen price target raised to $114 from $104 at Mizuho
02/08/21 Cowen
AmerisourceBergen price target raised to $150 from $145 at Cowen
02/04/21 Evercore ISI
AmerisourceBergen upgraded to Outperform after Q1 report at Evercore ISI
ABT Abbott
$124.37 /

+0.4 (+0.32%)

04/15/21 Atlantic Equities
Atlantic Equities starts Abbott at Neutral
04/15/21 Atlantic Equities
Abbott initiated with a Neutral at Atlantic Equities
03/16/21 Piper Sandler
Abbott study challenging Abiomed's Impella halted, says Piper Sandler
03/10/21 Wells Fargo
Wells says Quidel Covid testing comments not a direct read through to Abbott
ACAD Acadia Pharmaceuticals
$21.17 /

-0.02 (-0.09%)

04/07/21 Needham
Acadia price target lowered to $30 from $44 at Needham
04/07/21 H.C. Wainwright
Acadia downgraded to Neutral from Buy at H.C. Wainwright
04/06/21 SVB Leerink
Acadia price target lowered to $31 from $63 at SVB Leerink
04/06/21 Jefferies
Acadia downgraded to Hold at Jefferies after dementia-related psychosis CRL
ALNY Alnylam
$138.69 /

-0.23 (-0.17%)

02/22/21 Guggenheim
Alnylam downgraded to Neutral from Buy at Guggenheim
02/12/21
Fly Intel: Top five analyst downgrades
02/12/21 Barclays
Alnylam price target raised to $196 from $162 at Barclays
02/12/21 Citi
Alnylam downgraded to Neutral from Buy at Citi
BIIB Biogen
$270.07 /

-0.66 (-0.24%)

04/13/21 Roth Capital
Roth Capital sees Applied Genetic's XLRS licensing as vote of confidence
04/12/21 Oppenheimer
Sage Therapeutics data support 'enthusiasm' for SAGE-324 in ET, says Oppenheimer
04/12/21 Wedbush
Biogen price target raised to $245 from $236 at Wedbush
03/25/21 Piper Sandler
Piper says Biogen Tecfidera patents could change thesis, but sees unknowns
BMY Bristol-Myers
$65.46 /

+1.02 (+1.58%)

04/13/21 Truist
Bristol-Myers upgraded to Buy at Truist on improving pipeline asset visibility
04/13/21 Truist
Bristol-Myers upgraded to Buy from Hold at Truist
04/12/21 B. Riley
B. Riley calls Agenus the next Seagen, reiterates $8 target
03/08/21 BofA
Gartner added to US 1 List, Bristol-Myers removed at BofA
BHVN Biohaven Pharmaceutical
$74.37 /

-1.435 (-1.89%)

03/11/21
Fly Intel: Top five analyst initiations
03/11/21 UBS
Biohaven Pharmaceutical initiated with a Buy at UBS
03/02/21 Mizuho
Biohaven Pharmaceutical price target raised to $103 from $93 at Mizuho
CPRX Catalyst Pharmaceuticals
$4.44 /

-0.02 (-0.45%)

03/16/21 Piper Sandler
Catalyst business continues to generate cash flow, says Piper Sandler
01/07/21 Piper Sandler
Piper says Catalyst's Firdapse commercial business performing as expected
01/06/21 Piper Sandler
Catalyst Firdapse commercial business performing as expected, says Piper Sandler
11/10/20 Piper Sandler
Catalyst Pharmaceuticals price target lowered to $5.50 from $6 at Piper Sandler
DGX Quest Diagnostics
$130.09 /

+0.86 (+0.67%)

03/12/21 Baird
Quest Diagnostics downgraded to Neutral from Outperform at Baird
01/29/21 Citi
Quest Diagnostics price target raised to $158 from $151 at Citi
12/17/20 Morgan Stanley
Morgan Stanley cuts Quest Diagnostics to Equal Weight ahead of 2022 slowdown
12/17/20 Morgan Stanley
Quest Diagnostics downgraded to Equal Weight from Overweight at Morgan Stanley
DNA Bought by RHHBY
$94.97 /

+ (+0.00%)

HZNP Horizon Therapeutics
$93.25 /

-0.32 (-0.34%)

03/25/21 Guggenheim
Horizon Therapeutics price target raised to $120 from $115 at Guggenheim
03/22/21
Fly Intel: Top five analyst initiations
03/22/21 Morgan Stanley
Horizon Therapeutics resumed with an Overweight at Morgan Stanley
03/18/21 Citi
Horizon Therapeutics price target raised to $120 from $116 at Citi
LIVN LivaNova
$81.37 /

-1.46 (-1.76%)

04/13/21 Piper Sandler
LivaNova price target raised to $92 from $81 at Piper Sandler
03/03/21
Fly Intel: Top five analyst downgrades
03/03/21 Berenberg
Berenberg cuts LivaNova EPS forecasts on investments, downgrades to Hold
03/03/21 Berenberg
LivaNova downgraded to Hold from Buy at Berenberg
LLY Eli Lilly
$189.25 /

+3.28 (+1.76%)

04/12/21 Benchmark
Benchmark sees full FDA approval of Regeneron's REGEN-COV coming
04/06/21 JPMorgan
JPMorgan survey 'broadly positive' on Eli Lilly Alzheimer's drug
03/24/21 BMO Capital
AbCellera price target lowered to $59 from $61 at BMO Capital
03/17/21 Mizuho
AbbVie's FDA request show Xeljanz concerns may bleed to Rinvoq, says Mizuho
MDT Medtronic
$125.91 /

+0.06 (+0.05%)

04/15/21 Atlantic Equities
Atlantic Equities starts Medtronic at Overweight
04/15/21 Atlantic Equities
Medtronic initiated with an Overweight at Atlantic Equities
04/05/21 Citi
Citi opens positive catalyst watches on four medical supply stocks
02/24/21 Cowen
Medtronic price target raised to $135 from $120 at Cowen
NVS Novartis
$88.02 /

+0.81 (+0.93%)

04/05/21 Morgan Stanley
Regenxbio AAV9 patent challenged by Passage Bio, says Morgan Stanley
03/23/21 Societe Generale
Novartis price target raised to CHF 107 from CHF 104 at Societe Generale
03/22/21 Bernstein
Novartis initiated with a Market Perform at Bernstein
03/10/21
Fly Intel: Top five analyst downgrades
NVTA Invitae
$37.65 /

-1.47 (-3.76%)

04/05/21 Oppenheimer
Oppenheimer upgrades Invitae on valuation, sees potential high $50s stock
04/05/21 Oppenheimer
Invitae upgraded to Outperform from Perform at Oppenheimer
02/18/21 Ladenburg
Invitae upgraded to Buy with $58 price target at Ladenburg
02/18/21 Ladenburg
Invitae upgraded to Buy from Neutral at Ladenburg
PFE Pfizer
$38.57 /

+0.96 (+2.55%)

04/13/21 Morgan Stanley
Morgan Stanley says J&J news could improve 2022 outlook for mRNA vaccine makers
04/13/21 JPMorgan
Vaccine pause 'incremental negative' for J&J, says JPMorgan
04/09/21
Pfizer to host conference call
04/06/21 RBC Capital
Pfizer transferred with a Sector Perform at RBC Capital
PTCT PTC Therapeutics
$48.48 /

+0.33 (+0.69%)

03/29/21 RBC Capital
PTC Therapeutics upgraded to Sector Perform at RBC Capital on valuation
03/29/21 RBC Capital
PTC Therapeutics upgraded to Sector Perform from Underperform at RBC Capital
02/26/21 Cantor Fitzgerald
PTC Therapeutics price target lowered to $75 from $81 at Cantor Fitzgerald
02/12/21 BofA
PTC Therapeutics downgraded to Neutral from Buy at BofA
RETA Reata Pharmaceuticals
$90.83 /

-1.29 (-1.40%)

11/25/20 Citi
Reata Pharmaceuticals price target lowered to $234 from $260 at Citi
11/10/20 Cantor Fitzgerald
Reata Pharmaceuticals price target raised to $220 from $169 at Cantor Fitzgerald
11/10/20 Citi
Reata Pharmaceuticals price target raised to $260 from $244 at Citi
08/11/20 Cantor Fitzgerald
Reata Pharmaceuticals price target lowered to $169 from $275 at Cantor Fitzgerald
SNY Sanofi
$51.29 /

+0.63 (+1.24%)

04/06/21 Barclays
Sanofi price target raised to EUR 85 from EUR 80 at Barclays
02/23/21 BofA
BofA adds Heineken and IAG, removes Roche and Sanofi from Europe 1 list
02/10/21 Morgan Stanley
Sanofi price target raised to EUR 104 from EUR 101 at Morgan Stanley
02/05/21 Piper Sandler
Piper reiterates Overweight on Kymera after Sanofi capital markets day
SUPN Supernus
$31.72 /

-0.09 (-0.28%)

04/13/21 Jefferies
Supernus upgraded to Buy after survey work at Jefferies
04/13/21 Jefferies
Supernus upgraded to Buy from Hold at Jefferies
02/03/21 Piper Sandler
Supernus price target raised to $35 from $30 at Piper Sandler
06/16/20 Piper Sandler
Supernus upgraded to Overweight from Neutral at Piper Sandler
TAK Takeda Pharmaceutical
$17.08 /

-0.13 (-0.76%)

04/19/21 JPMorgan
Takeda Pharmaceutical downgraded to Neutral on R&D investments at JPMorgan
04/19/21 JPMorgan
Takeda Pharmaceutical downgraded to Neutral from Overweight at JPMorgan
04/15/21 Oppenheimer
Molecular Templates price target lowered to $13 from $18 at Oppenheimer
04/05/21
Fly Intel: Top five analyst downgrades
TEVA Teva
$10.75 /

-0.08 (-0.74%)

04/06/21 RBC Capital
Teva transferred with a Sector Perform at RBC Capital
01/26/21 Piper Sandler
Amarin in 'strong position' against Health Net, says Piper Sandler
12/21/20 Gabelli
Teva named 'Best Idea for 2021' at Gabelli
11/27/20 H.C. Wainwright
Corcept Therapeutics price target raised to $32 from $22 at H.C. Wainwright
TGTX TG Therapeutics
$44.79 /

-1.05 (-2.29%)

04/19/21 Cantor Fitzgerald
TG Therapeutics price target raised to $74 from $68 at Cantor Fitzgerald
04/19/21 H.C. Wainwright
TG Therapeutics price target raised to $89 from $79 at H.C. Wainwright
03/04/21 B. Riley
TG Therapeutics price target lowered to $91 from $95 at B. Riley Securities
02/09/21 B. Riley
TG Therapeutics price target raised to $95 from $90 at B. Riley Securities
ZGNX Zogenix
$19.00 /

-0.65 (-3.31%)

04/06/21 Evercore ISI
Evercore starts 'compelling' Arena spinoff Longboard at Outperform
04/06/21 Citi
Longboard Pharmaceuticals initiated with a Buy at Citi
02/03/21 Mizuho
Jazz deal for GW Pharma has positive read through to Zogenix, says Mizuho
12/04/20 Mizuho
Zogenix collaboration step in right direction, says Mizuho
AVDL Avadel Pharmaceuticals
$8.65 /

+0.09 (+1.05%)

03/10/21 H.C. Wainwright
Avadel Pharmaceuticals price target raised to $17 from $15 at H.C. Wainwright
01/25/21 Craig-Hallum
Avadel Pharmaceuticals assumed with a Buy rating at Craig-Hallum
08/28/20 Oppenheimer
Uwarranted pressure creates buying opportunity for Avadel, says Oppenheimer
08/28/20 SVB Leerink
Avadel selloff on Jazz competition worries overdone, says SVB Leerink
JNJ Johnson & Johnson
$162.24 /

+1.74 (+1.08%)

04/19/21 Chardan
Chardan sees J&J moving forward with Emergent if observations are minor
04/14/21 Guggenheim
Emergent BioSolutions price target lowered to $110 from $130 at Guggenheim
04/13/21 Goldman Sachs
J&J vaccine had numerical blood clot imbalance in trial, says Goldman Sachs
ZGNX Zogenix
$19.00 /

-0.65 (-3.31%)

TGTX TG Therapeutics
$44.79 /

-1.05 (-2.29%)

TEVA Teva
$10.75 /

-0.08 (-0.74%)

TAK Takeda Pharmaceutical
$17.08 /

-0.13 (-0.76%)

SUPN Supernus
$31.72 /

-0.09 (-0.28%)

SNY Sanofi
$51.29 /

+0.63 (+1.24%)

RETA Reata Pharmaceuticals
$90.83 /

-1.29 (-1.40%)

PTCT PTC Therapeutics
$48.48 /

+0.33 (+0.69%)

PFE Pfizer
$38.57 /

+0.96 (+2.55%)

NVTA Invitae
$37.65 /

-1.47 (-3.76%)

NVS Novartis
$88.02 /

+0.81 (+0.93%)

MDT Medtronic
$125.91 /

+0.06 (+0.05%)

LLY Eli Lilly
$189.25 /

+3.28 (+1.76%)

LIVN LivaNova
$81.37 /

-1.46 (-1.76%)

JNJ Johnson & Johnson
$162.24 /

+1.74 (+1.08%)

HZNP Horizon Therapeutics
$93.25 /

-0.32 (-0.34%)

DGX Quest Diagnostics
$130.09 /

+0.86 (+0.67%)

CPRX Catalyst Pharmaceuticals
$4.44 /

-0.02 (-0.45%)

BMY Bristol-Myers
$65.46 /

+1.02 (+1.58%)

BIIB Biogen
$270.07 /

-0.66 (-0.24%)

BHVN Biohaven Pharmaceutical
$74.37 /

-1.435 (-1.89%)

AVDL Avadel Pharmaceuticals
$8.65 /

+0.09 (+1.05%)

ALNY Alnylam
$138.69 /

-0.23 (-0.17%)

ACAD Acadia Pharmaceuticals
$21.17 /

-0.02 (-0.09%)

ABT Abbott
$124.37 /

+0.4 (+0.32%)

ABC AmerisourceBergen
$119.62 /

+0.55 (+0.46%)

ABBV AbbVie
$107.93 /

+1.05 (+0.98%)

  • 16
    Mar
  • 22
    Jan
  • 15
    Dec
  • 02
    Dec
  • 07
    Aug
  • 15
    May
  • 29
    Apr
TEVA Teva
$10.75 /

-0.08 (-0.74%)

SNY Sanofi
$51.29 /

+0.63 (+1.24%)

PFE Pfizer
$38.57 /

+0.96 (+2.55%)

NVS Novartis
$88.02 /

+0.81 (+0.93%)

LLY Eli Lilly
$189.25 /

+3.28 (+1.76%)

LIVN LivaNova
$81.37 /

-1.46 (-1.76%)

JNJ Johnson & Johnson
$162.24 /

+1.74 (+1.08%)

BMY Bristol-Myers
$65.46 /

+1.02 (+1.58%)

BIIB Biogen
$270.07 /

-0.66 (-0.24%)

ALNY Alnylam
$138.69 /

-0.23 (-0.17%)

ABT Abbott
$124.37 /

+0.4 (+0.32%)

ABC AmerisourceBergen
$119.62 /

+0.55 (+0.46%)

ABBV AbbVie
$107.93 /

+1.05 (+0.98%)

ZGNX Zogenix
$19.00 /

-0.65 (-3.31%)

TGTX TG Therapeutics
$44.79 /

-1.05 (-2.29%)

TEVA Teva
$10.75 /

-0.08 (-0.74%)

TAK Takeda Pharmaceutical
$17.08 /

-0.13 (-0.76%)

SUPN Supernus
$31.72 /

-0.09 (-0.28%)

SNY Sanofi
$51.29 /

+0.63 (+1.24%)

RETA Reata Pharmaceuticals
$90.83 /

-1.29 (-1.40%)

PTCT PTC Therapeutics
$48.48 /

+0.33 (+0.69%)

PFE Pfizer
$38.57 /

+0.96 (+2.55%)

NVTA Invitae
$37.65 /

-1.47 (-3.76%)

NVS Novartis
$88.02 /

+0.81 (+0.93%)

LLY Eli Lilly
$189.25 /

+3.28 (+1.76%)

JNJ Johnson & Johnson
$162.24 /

+1.74 (+1.08%)

HZNP Horizon Therapeutics
$93.25 /

-0.32 (-0.34%)

DGX Quest Diagnostics
$130.09 /

+0.86 (+0.67%)

CPRX Catalyst Pharmaceuticals
$4.44 /

-0.02 (-0.45%)

BMY Bristol-Myers
$65.46 /

+1.02 (+1.58%)

BIIB Biogen
$270.07 /

-0.66 (-0.24%)

BHVN Biohaven Pharmaceutical
$74.37 /

-1.435 (-1.89%)

AVDL Avadel Pharmaceuticals
$8.65 /

+0.09 (+1.05%)

ACAD Acadia Pharmaceuticals
$21.17 /

-0.02 (-0.09%)

ABT Abbott
$124.37 /

+0.4 (+0.32%)

ABC AmerisourceBergen
$119.62 /

+0.55 (+0.46%)

ABBV AbbVie
$107.93 /

+1.05 (+0.98%)

ZGNX Zogenix
$19.00 /

-0.65 (-3.31%)

TGTX TG Therapeutics
$44.79 /

-1.05 (-2.29%)

TEVA Teva
$10.75 /

-0.08 (-0.74%)

TAK Takeda Pharmaceutical
$17.08 /

-0.13 (-0.76%)

PFE Pfizer
$38.57 /

+0.96 (+2.55%)

NVTA Invitae
$37.65 /

-1.47 (-3.76%)

MDT Medtronic
$125.91 /

+0.06 (+0.05%)

LLY Eli Lilly
$189.25 /

+3.28 (+1.76%)

JNJ Johnson & Johnson
$162.24 /

+1.74 (+1.08%)

HZNP Horizon Therapeutics
$93.25 /

-0.32 (-0.34%)

DGX Quest Diagnostics
$130.09 /

+0.86 (+0.67%)

BMY Bristol-Myers
$65.46 /

+1.02 (+1.58%)

BIIB Biogen
$270.07 /

-0.66 (-0.24%)

ABT Abbott
$124.37 /

+0.4 (+0.32%)

ABC AmerisourceBergen
$119.62 /

+0.55 (+0.46%)

ABBV AbbVie
$107.93 /

+1.05 (+0.98%)

Downgrade
Takeda Pharmaceutical downgraded to Neutral on R&D investments at JPMorgan » 09:04
04/19/21
04/19
09:04
04/19/21
09:04
TAK

Takeda Pharmaceutical

$17.08 /

-0.13 (-0.76%)

As previously reported,…

As previously reported, JPMorgan analyst Seiji Wakao downgraded Takeda Pharmaceutical to Neutral from Overweight with a 4,200 yen price target following the announcements made at the company's R&D briefing held on April 6. While the analyst takes "a positive view of the good trial results for TAK-994," Wakao expects profits to fall given the company's plans to increase R&D spending to Y500-550B in FY21 and maintain spending at this level from FY22 and beyond.

ShowHide Related Items >><<
TAK Takeda Pharmaceutical
$17.08 /

-0.13 (-0.76%)

TAK Takeda Pharmaceutical
$17.08 /

-0.13 (-0.76%)

04/19/21 JPMorgan
Takeda Pharmaceutical downgraded to Neutral from Overweight at JPMorgan
04/15/21 Oppenheimer
Molecular Templates price target lowered to $13 from $18 at Oppenheimer
04/05/21
Fly Intel: Top five analyst downgrades
04/05/21 Barclays
Molecular Templates MT-3724 discontinuation shouldn't be surprise, says Barclays
TAK Takeda Pharmaceutical
$17.08 /

-0.13 (-0.76%)

TAK Takeda Pharmaceutical
$17.08 /

-0.13 (-0.76%)

TAK Takeda Pharmaceutical
$17.08 /

-0.13 (-0.76%)

Downgrade
Takeda Pharmaceutical downgraded to Neutral from Overweight at JPMorgan » 09:00
04/19/21
04/19
09:00
04/19/21
09:00
TAK

Takeda Pharmaceutical

$17.08 /

-0.13 (-0.76%)

JPMorgan analyst Seiji…

JPMorgan analyst Seiji Wakao downgraded Takeda Pharmaceutical to Neutral from Overweight with a 4,200 yen price target.

ShowHide Related Items >><<
TAK Takeda Pharmaceutical
$17.08 /

-0.13 (-0.76%)

TAK Takeda Pharmaceutical
$17.08 /

-0.13 (-0.76%)

04/15/21 Oppenheimer
Molecular Templates price target lowered to $13 from $18 at Oppenheimer
04/05/21
Fly Intel: Top five analyst downgrades
04/05/21 Barclays
Molecular Templates MT-3724 discontinuation shouldn't be surprise, says Barclays
04/05/21 Jefferies
Takeda Pharmaceutical downgraded to Hold from Buy at Jefferies
TAK Takeda Pharmaceutical
$17.08 /

-0.13 (-0.76%)

TAK Takeda Pharmaceutical
$17.08 /

-0.13 (-0.76%)

TAK Takeda Pharmaceutical
$17.08 /

-0.13 (-0.76%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.